FEED Validator

for Atom and RSS and KML

Congratulations!

This is a valid RSS feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

line 39, column 0: description should not contain decoding attribute (6 occurrences) [help]
```
					<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" ...
```
line 73, column 0: content:encoded should not contain decoding attribute (35 occurrences) [help]
```
										<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img wi ...
```
line 119, column 0: description should not contain loading attribute (5 occurrences) [help]
```
					<description><![CDATA[<div style="margin-bottom:20px;"><img width="120" ...
```
line 139, column 0: content:encoded should not contain loading attribute (14 occurrences) [help]
```
										<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img wi ...
```

line 171, column 0: description should not contain sizes attribute [help]

					<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" ...

line 190, column 0: content:encoded should not contain sizes attribute [help]

										<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img wi ...

line 231, column 0: content:encoded should not contain data-mce-src attribute (7 occurrences) [help]
```
<img loading="lazy" decoding="async" data-mce-src="/ap ...
```
line 231, column 0: content:encoded should not contain data-mce-style attribute (3 occurrences) [help]
```
<img loading="lazy" decoding="async" data-mce-src="/ap ...
```
line 231, column 0: content:encoded should not contain data-state attribute (3 occurrences) [help]
```
<img loading="lazy" decoding="async" data-mce-src="/ap ...
```
line 258, column 0: style attribute contains potentially dangerous content: width:301.34px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; (179 occurrences) [help]
```
<td style="width:301.34px;;border-top: solid black 1pt ; border-right: solid ...
```
line 321, column 0: content:encoded should not contain referrerpolicy attribute (4 occurrences) [help]
```
<img alt="" src='https://ml.globenewswire.com/media/NjI2OTMzMDktYTVjZC00Z ...
```

Source: https://dailyindianews.com/feed/

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
<title>Daily India News</title>
<atom:link href="https://dailyindianews.com/feed/" rel="self" type="application/rss+xml" />
<link>https://dailyindianews.com</link>
<description>Latest breaking news headlines</description>
<lastBuildDate>Tue, 02 Sep 2025 08:57:00 +0000</lastBuildDate>
<language>en-US</language>
<sy:updatePeriod>
hourly </sy:updatePeriod>
<sy:updateFrequency>
1 </sy:updateFrequency>
<generator>https://wordpress.org/?v=6.8.2</generator>
<image>
<url>https://dailyindianews.com/wp-content/uploads/2021/10/favicon-150x150.png</url>
<title>Daily India News</title>
<link>https://dailyindianews.com</link>
<width>32</width>
<height>32</height>
</image>
<item>
<title>ICFAI Business School Equips Students with Bloomberg, SAP Labs</title>
<link>https://dailyindianews.com/icfai-business-school-equips-students-with-bloomberg-sap-labs/2025/377550/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 02 Sep 2025 08:57:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/icfai-business-school-equips-students-with-bloomberg-sap-labs</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="72" src="https://dailyindianews.com/wp-content/uploads/2025/09/icfai-business-school-equips-students-with-bloomberg-sap-labs.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" /></div>
HYDERABAD, India, Sept. 2, 2025 /PRNewswire/ -- <a href="https://ibsindia.org/" target="_blank" rel="nofollow">ICFAI Business School (IBS)</a> has always believed that the best way to prepare future managers is by giving them not just academic knowledge, but also practical exposure to the real-world tools that global businesses rely on. Staying true to this vision, ICFAI Business School (IBS) has equipped all its nine campuses with two advanced learning facilities that place its students ahead of the curve — the Bloomberg Lab and the SAP Lab. Together, they bridge the gap between classroom learning and industry practice, offering students the confidence and skills to thrive in competitive corporate environments.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <a href="https://mma.prnewswire.com/media/2762307/Bloomberg_SAP_Lab_IBS.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2762307/Bloomberg_SAP_Lab_IBS.jpg" title="Bloomberg-SAP Lab at ICFAI Business School" alt="Bloomberg-SAP Lab at ICFAI Business School"></img> </a> 
</div>
Bloomberg labs bring global finance into the classroom
In today's fast-paced business environment, access to real-time data and insights is critical. To prepare students for this reality, ICFAI Business School (IBS) provides Bloomberg Terminals to students across all campuses. Bloomberg is the world's leading platform for financial news, data, analytics, and research. Trusted by asset managers, business leaders, and policymakers worldwide, it brings global financial leadership directly into the classroom.
The Bloomberg Lab allows students to work in simulated market environments, where they can analyze financial markets, assess economic scenarios, and interpret global developments that influence economies and corporations. For students, this means going beyond theory into practice: testing strategies, studying market movements, and learning how financial decisions are made in real time.
This exposure ensures <a href="https://ibsindia.org/" target="_blank" rel="nofollow">that ICFAI Business School (IBS</a>) graduates can confidently step into roles in investment banking, asset management, consulting, or corporate finance. They do not just read about financial markets; they experience how they function, gaining a level of practical familiarity that distinguishes them in job interviews and boardrooms alike.
Adding to this advantage, ICFAI Business School (IBS) students receive free access to the Bloomberg Market Concepts (BMC) certification. This interactive program introduces them to over 70 Bloomberg functions, covering topics such as economics, fixed income, equities, and portfolio management. Completing this certification provides students with a recognized credential that adds weight to their résumés and demonstrates their preparedness to recruiters.
The Bloomberg platform also fosters analytical skills. By working with real-time, verified data, students learn to evaluate information critically, develop insights, and create tools for decision-making. In essence, the Bloomberg Lab helps ICFAI Business School (IBS) students build the same expertise that senior professionals in financial institutions and government agencies depend on every day.
SAP Lab: Understanding how businesses run
While Bloomberg prepares students for financial decision-making, the SAP Lab equips them with a deep understanding of how organizations function internally. In Semester III, a core course called Business Process Integration is taught in computer labs using SAP's advanced software systems.
Students work with SAP S/4 HANA, the leading enterprise resource planning (ERP) platform used by top companies worldwide. They also explore SAP's Vision of the Intelligent Enterprise and engage with the SAP Fiori User Interface, which allows them to experience firsthand how modern organizations manage data, workflows, and decision-making processes.
Through this lab, students are introduced to the entire spectrum of business operations. From supply chain management (SD, MM, PP) and finance (FI, CO) to human resources (HCM), project systems (PS), asset management (EAM), and customer service (CS, QM), they understand how different business functions are integrated through ERP systems. This is further reinforced with case studies that replicate real-world corporate challenges.
One of the highlights of the SAP Lab is its use of business simulation games. These interactive tools enable students to manage virtual companies using SAP S/4 HANA, helping them see how decisions in procurement, production, or finance ripple across the entire organization. Such exercises sharpen decision-making skills, strategic thinking, and cross-functional awareness.
Beyond ERP, students also gain exposure to cutting-edge applications such as Data Mining, Geospatial Processing, Text Analytics, and Graph Processing. These areas are becoming increasingly relevant as businesses rely on big data and advanced analytics for competitive advantage.
For ICFAI Business School (IBS) students, the SAP Lab is more than a course requirement; it is preparation for the workplace. Recruiters value candidates who already have practical familiarity with ERP systems, as it reduces the learning curve when they enter the job market. This hands-on exposure gives IBS graduates an edge in interviews and ensures they can contribute effectively from day one.
A distinctive edge for ICFAI Business School (IBS) graduates
Together, the Bloomberg and SAP Labs underscore IBS's commitment to holistic learning. They represent the institution's philosophy of combining theory with practice, ensuring students are not only well-versed in management principles but also equipped with industry-standard tools.
While many business schools teach management concepts in theory, ICFAI Business School (IBS) ensures that its students apply these concepts in real-world contexts. By working on Bloomberg Terminals, they learn how to interpret global financial events. By working with SAP systems, they learn how to integrate and streamline business processes. This dual exposure ensures that ICFAI Business School (IBS) graduates are industry-ready, capable of adapting to diverse roles across finance, consulting, operations, analytics, and technology-driven businesses.
What truly sets ICFAI Business School (IBS) apart is that these facilities are not limited to one flagship campus. All nine campuses — Hyderabad, Ahmedabad, Bangalore, Gurgaon, Jaipur, Kolkata, Mumbai, Pune, and Dehradun — provide students access to Bloomberg and SAP Labs. This democratization of resources reflects IBS's belief that every student, regardless of location, should have equal opportunity to benefit from world-class infrastructure.
For more information visit <a href="https://ibsindia.org/" target="_blank" rel="nofollow">https://ibsindia.org/</a>. 
Contact us 
IBS Admission Office Plot No.65, Nagarjuna Hills Punjagutta, Hyderabad - 500082 Telangana Ph 040-23440963 (5 lines) Toll Free: 1800 425 55 66 77 Email: <a href="mailto:ibsat@ibsindia.org" target="_blank" rel="nofollow">ibsat@ibsindia.org</a> Visit: <a href="https://ibsindia.org/" target="_blank" rel="nofollow">ibsindia.org</a>
Photo: <a href="https://mma.prnewswire.com/media/2762307/Bloomberg_SAP_Lab_IBS.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2762307/Bloomberg_SAP_Lab_IBS.jpg</a> Logo: <a href="https://mma.prnewswire.com/media/1023356/IBS_Logo.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/1023356/IBS_Logo.jpg</a>
 
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 <a href="https://mma.prnewswire.com/media/1023356/IBS_Logo.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/1023356/IBS_Logo.jpg" title="ICFAI Business School (IBS) Logo (PRNewsfoto/ICFAI Business School (IBS))" alt="ICFAI Business School (IBS) Logo (PRNewsfoto/ICFAI Business School (IBS))"></img> </a> 
</div>
<img title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN63136&sd=2025-09-02"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/in/news-releases/icfai-business-school-equips-students-with-bloomberg-sap-labs-302543606.html" target="_blank">https://www.prnewswire.com/in/news-releases/icfai-business-school-equips-students-with-bloomberg-sap-labs-302543606.html</a>
 <img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN63136&Transmission_Id=202509020457PR_NEWS_EURO_ND__EN63136&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>
The post <a rel="nofollow" href="https://dailyindianews.com/icfai-business-school-equips-students-with-bloomberg-sap-labs/2025/377550/">ICFAI Business School Equips Students with Bloomberg, SAP Labs</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="72" src="https://dailyindianews.com/wp-content/uploads/2025/09/icfai-business-school-equips-students-with-bloomberg-sap-labs.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" /></div>HYDERABAD, India, Sept. 2, 2025 /PRNewswire/ — ICFAI Business School (IBS) has always believed that the best way to prepare future managers is by giving them not just academic knowledge, but also practical exposure to the real-world tools that global businesses rely on. Staying true to this vision, ICFAI Business School (IBS) has equipped all its nine campuses with two advanced learning facilities that place its students ahead of the curve — the Bloomberg Lab and the SAP Lab. Together, they bridge the gap between classroom learning and industry practice, offering students the confidence and skills to thrive in competitive corporate environments.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" src="https://mma.prnewswire.com/media/2762307/Bloomberg_SAP_Lab_IBS.jpg" title="Bloomberg-SAP Lab at ICFAI Business School" alt="Bloomberg-SAP Lab at ICFAI Business School"></img> 
</div>
Bloomberg labs bring global finance into the classroom
In today’s fast-paced business environment, access to real-time data and insights is critical. To prepare students for this reality, ICFAI Business School (IBS) provides Bloomberg Terminals to students across all campuses. Bloomberg is the world’s leading platform for financial news, data, analytics, and research. Trusted by asset managers, business leaders, and policymakers worldwide, it brings global financial leadership directly into the classroom.
The Bloomberg Lab allows students to work in simulated market environments, where they can analyze financial markets, assess economic scenarios, and interpret global developments that influence economies and corporations. For students, this means going beyond theory into practice: testing strategies, studying market movements, and learning how financial decisions are made in real time.
This exposure ensures that ICFAI Business School (IBS) graduates can confidently step into roles in investment banking, asset management, consulting, or corporate finance. They do not just read about financial markets; they experience how they function, gaining a level of practical familiarity that distinguishes them in job interviews and boardrooms alike.
Adding to this advantage, ICFAI Business School (IBS) students receive free access to the Bloomberg Market Concepts (BMC) certification. This interactive program introduces them to over 70 Bloomberg functions, covering topics such as economics, fixed income, equities, and portfolio management. Completing this certification provides students with a recognized credential that adds weight to their résumés and demonstrates their preparedness to recruiters.
The Bloomberg platform also fosters analytical skills. By working with real-time, verified data, students learn to evaluate information critically, develop insights, and create tools for decision-making. In essence, the Bloomberg Lab helps ICFAI Business School (IBS) students build the same expertise that senior professionals in financial institutions and government agencies depend on every day.
SAP Lab: Understanding how businesses run
While Bloomberg prepares students for financial decision-making, the SAP Lab equips them with a deep understanding of how organizations function internally. In Semester III, a core course called Business Process Integration is taught in computer labs using SAP’s advanced software systems.
Students work with SAP S/4 HANA, the leading enterprise resource planning (ERP) platform used by top companies worldwide. They also explore SAP’s Vision of the Intelligent Enterprise and engage with the SAP Fiori User Interface, which allows them to experience firsthand how modern organizations manage data, workflows, and decision-making processes.
Through this lab, students are introduced to the entire spectrum of business operations. From supply chain management (SD, MM, PP) and finance (FI, CO) to human resources (HCM), project systems (PS), asset management (EAM), and customer service (CS, QM), they understand how different business functions are integrated through ERP systems. This is further reinforced with case studies that replicate real-world corporate challenges.
One of the highlights of the SAP Lab is its use of business simulation games. These interactive tools enable students to manage virtual companies using SAP S/4 HANA, helping them see how decisions in procurement, production, or finance ripple across the entire organization. Such exercises sharpen decision-making skills, strategic thinking, and cross-functional awareness.
Beyond ERP, students also gain exposure to cutting-edge applications such as Data Mining, Geospatial Processing, Text Analytics, and Graph Processing. These areas are becoming increasingly relevant as businesses rely on big data and advanced analytics for competitive advantage.
For ICFAI Business School (IBS) students, the SAP Lab is more than a course requirement; it is preparation for the workplace. Recruiters value candidates who already have practical familiarity with ERP systems, as it reduces the learning curve when they enter the job market. This hands-on exposure gives IBS graduates an edge in interviews and ensures they can contribute effectively from day one.
A distinctive edge for ICFAI Business School (IBS) graduates
Together, the Bloomberg and SAP Labs underscore IBS’s commitment to holistic learning. They represent the institution’s philosophy of combining theory with practice, ensuring students are not only well-versed in management principles but also equipped with industry-standard tools.
While many business schools teach management concepts in theory, ICFAI Business School (IBS) ensures that its students apply these concepts in real-world contexts. By working on Bloomberg Terminals, they learn how to interpret global financial events. By working with SAP systems, they learn how to integrate and streamline business processes. This dual exposure ensures that ICFAI Business School (IBS) graduates are industry-ready, capable of adapting to diverse roles across finance, consulting, operations, analytics, and technology-driven businesses.
What truly sets ICFAI Business School (IBS) apart is that these facilities are not limited to one flagship campus. All nine campuses — Hyderabad, Ahmedabad, Bangalore, Gurgaon, Jaipur, Kolkata, Mumbai, Pune, and Dehradun — provide students access to Bloomberg and SAP Labs. This democratization of resources reflects IBS’s belief that every student, regardless of location, should have equal opportunity to benefit from world-class infrastructure.
For more information visit https://ibsindia.org/. 
Contact us 
IBS Admission Office Plot No.65, Nagarjuna Hills Punjagutta, Hyderabad – 500082 Telangana Ph 040-23440963 (5 lines) Toll Free: 1800 425 55 66 77 Email: ibsat@ibsindia.org Visit: ibsindia.org 
Photo: https://mma.prnewswire.com/media/2762307/Bloomberg_SAP_Lab_IBS.jpg Logo: https://mma.prnewswire.com/media/1023356/IBS_Logo.jpg
 
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 <img decoding="async" src="https://mma.prnewswire.com/media/1023356/IBS_Logo.jpg" title="ICFAI Business School (IBS) Logo (PRNewsfoto/ICFAI Business School (IBS))" alt="ICFAI Business School (IBS) Logo (PRNewsfoto/ICFAI Business School (IBS))"></img> 
</div>
<img decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN63136&sd=2025-09-02"></img> View original content to download multimedia:https://www.prnewswire.com/in/news-releases/icfai-business-school-equips-students-with-bloomberg-sap-labs-302543606.html
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN63136&Transmission_Id=202509020457PR_NEWS_EURO_ND__EN63136&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Daily India News takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/icfai-business-school-equips-students-with-bloomberg-sap-labs/2025/377550/">ICFAI Business School Equips Students with Bloomberg, SAP Labs</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>Herbalife India Honored with ‘Sustainable Supply Chain Award’ at BIGBOX India 2025</title>
<link>https://dailyindianews.com/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025/2025/377548/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 02 Sep 2025 08:23:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="120" height="144" src="https://dailyindianews.com/wp-content/uploads/2025/09/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- Herbalife India, a premier health and wellness company, community, and platform, proudly announces its recognition with the prestigious 'Sustainable Supply Chain Award' at BIGBOX India 2025. The summit brought together India's most innovative individuals in e-commerce and retail to discuss new trends and determine how consumers will interact with brands in the digital age.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <a href="https://mma.prnewswire.com/media/2762294/Herbalife_Team.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2762294/Herbalife_Team.jpg" title="Herbalife India being honored with the prestigious Sustainable Supply Chain Award." alt="Herbalife India being honored with the prestigious Sustainable Supply Chain Award."></img> </a> 
</div>
This recognition underscores Herbalife India's unwavering commitment to supply chain excellence and environmental responsibility. The platform's acknowledgment reflects the company's continued focus on embedding sustainable practices in line with the evolving market landscape.
"We are truly honoured to receive this recognition on such a prestigious platform," said Ajay Khanna, Managing Director, Herbalife India. "This award is a testament to our unwavering efforts to embed sustainability across every stage of our operations—from responsible sourcing to product delivery. It also reinforces our commitment to ethical business practices and our vision of building a healthier, more sustainable world for people and communities", he added.
The BIGBOX India 2025 summit brought together retail and e-commerce leaders, innovators, and changemakers to explore the future of India's dynamic marketplace. The event highlighted omnichannel strategies, quick commerce, AI-driven personalization, and emerging D2C models, while addressing infrastructure and regulatory challenges. It served as a platform for knowledge sharing, collaboration, and partnerships, offering actionable insights to drive sustainable growth and innovation across the evolving retail ecosystem. Herbalife India's recognition at the event defends its leadership in driving sustainable practices within the retail and e-commerce market.
About Herbalife International India Private Ltd. 
Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed food products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life. For more information, visit <a href="https://www.herbalife.com/en-in" target="_blank" rel="nofollow">https://www.herbalife.com/en-in</a>
Photo: <a href="https://mma.prnewswire.com/media/2762294/Herbalife_Team.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2762294/Herbalife_Team.jpg</a> Photo: <a href="https://mma.prnewswire.com/media/2762295/BigBox_2025_award.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2762295/BigBox_2025_award.jpg</a> Logo: <a href="https://mma.prnewswire.com/media/2238437/4372842/Herbalife_Logo.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2238437/4372842/Herbalife_Logo.jpg</a>
 
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 <a href="https://mma.prnewswire.com/media/2762295/BigBox_2025_award.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2762295/BigBox_2025_award.jpg" title="BIGBOX India 2025" alt="BIGBOX India 2025"></img> </a> 
 <a href="https://mma.prnewswire.com/media/2238437/Herbalife_Logo.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2238437/Herbalife_Logo.jpg" title="Herbalife Logo (PRNewsfoto/Herbalife India)" alt="Herbalife Logo (PRNewsfoto/Herbalife India)"></img> </a> 
</div>
<img title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN63127&sd=2025-09-02"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/in/news-releases/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025-302543583.html" target="_blank">https://www.prnewswire.com/in/news-releases/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025-302543583.html</a>
 <img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN63127&Transmission_Id=202509020423PR_NEWS_EURO_ND__EN63127&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>
The post <a rel="nofollow" href="https://dailyindianews.com/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025/2025/377548/">Herbalife India Honored with ‘Sustainable Supply Chain Award’ at BIGBOX India 2025</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="120" height="144" src="https://dailyindianews.com/wp-content/uploads/2025/09/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>BENGALURU, India, Sept. 2, 2025 /PRNewswire/ — Herbalife India, a premier health and wellness company, community, and platform, proudly announces its recognition with the prestigious ‘Sustainable Supply Chain Award’ at BIGBOX India 2025. The summit brought together India’s most innovative individuals in e-commerce and retail to discuss new trends and determine how consumers will interact with brands in the digital age.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" src="https://mma.prnewswire.com/media/2762294/Herbalife_Team.jpg" title="Herbalife India being honored with the prestigious Sustainable Supply Chain Award." alt="Herbalife India being honored with the prestigious Sustainable Supply Chain Award."></img> 
</div>
This recognition underscores Herbalife India’s unwavering commitment to supply chain excellence and environmental responsibility. The platform’s acknowledgment reflects the company’s continued focus on embedding sustainable practices in line with the evolving market landscape.
“We are truly honoured to receive this recognition on such a prestigious platform,” said Ajay Khanna, Managing Director, Herbalife India. “This award is a testament to our unwavering efforts to embed sustainability across every stage of our operations—from responsible sourcing to product delivery. It also reinforces our commitment to ethical business practices and our vision of building a healthier, more sustainable world for people and communities”, he added.
The BIGBOX India 2025 summit brought together retail and e-commerce leaders, innovators, and changemakers to explore the future of India’s dynamic marketplace. The event highlighted omnichannel strategies, quick commerce, AI-driven personalization, and emerging D2C models, while addressing infrastructure and regulatory challenges. It served as a platform for knowledge sharing, collaboration, and partnerships, offering actionable insights to drive sustainable growth and innovation across the evolving retail ecosystem. Herbalife India’s recognition at the event defends its leadership in driving sustainable practices within the retail and e-commerce market.
About Herbalife International India Private Ltd. 
Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people’s lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed food products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life. For more information, visit https://www.herbalife.com/en-in
Photo: https://mma.prnewswire.com/media/2762294/Herbalife_Team.jpg Photo: https://mma.prnewswire.com/media/2762295/BigBox_2025_award.jpg Logo: https://mma.prnewswire.com/media/2238437/4372842/Herbalife_Logo.jpg 
 
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 <img decoding="async" src="https://mma.prnewswire.com/media/2762295/BigBox_2025_award.jpg" title="BIGBOX India 2025" alt="BIGBOX India 2025"></img> 
 <img decoding="async" src="https://mma.prnewswire.com/media/2238437/Herbalife_Logo.jpg" title="Herbalife Logo (PRNewsfoto/Herbalife India)" alt="Herbalife Logo (PRNewsfoto/Herbalife India)"></img> 
</div>
<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN63127&sd=2025-09-02"></img> View original content to download multimedia:https://www.prnewswire.com/in/news-releases/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025-302543583.html
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN63127&Transmission_Id=202509020423PR_NEWS_EURO_ND__EN63127&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Daily India News takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/herbalife-india-honored-with-sustainable-supply-chain-award-at-bigbox-india-2025/2025/377548/">Herbalife India Honored with ‘Sustainable Supply Chain Award’ at BIGBOX India 2025</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>slice strengthens board with former RBI executive</title>
<link>https://dailyindianews.com/slice-strengthens-board-with-former-rbi-executive/2025/377543/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 02 Sep 2025 06:24:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/slice-strengthens-board-with-former-rbi-executive</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="144" src="https://dailyindianews.com/wp-content/uploads/2025/09/slice-strengthens-board-with-former-rbi-executive.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://dailyindianews.com/wp-content/uploads/2025/09/slice-strengthens-board-with-former-rbi-executive.jpg 144w, https://dailyindianews.com/wp-content/uploads/2025/09/slice-strengthens-board-with-former-rbi-executive-100x100.jpg 100w" sizes="auto, (max-width: 144px) 100vw, 144px" /></div>
BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- slice, which aims to build India's most loved bank, has appointed Eugene Emmanuel Karthak, a former Executive Director at the Reserve Bank of India, as Part-time Chairman and Independent Director to its Bank Board.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <a href="https://mma.prnewswire.com/media/2762213/Eugene_Emmanuel_Karthak_slice.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2762213/Eugene_Emmanuel_Karthak_slice.jpg" title="Eugene Emmanuel Karthak, Part-time Chairman and Independent Director, slice" alt="Eugene Emmanuel Karthak, Part-time Chairman and Independent Director, slice"></img> </a> 
</div>
Mr. Karthak previously served on the board of slice's parent company Garagepreneurs Internet Private Limited (GIPL) before its banking merger and his continuation with the bank shows stability during a critical growth phase for the company.
With over three decades at India's central bank, Mr. Karthak led the Information Technology and Corporate Services departments, etc, and also served as Regional Director in RBI Delhi and Bengaluru, where he strengthened regulatory compliance and policy implementation across multiple institutions. He also participated in several high-level RBI committees throughout his tenure.
His governance experience extends to prior board positions at Andhra Bank as RBI Nominee Director and Jana Small Finance Bank as Independent Director. He currently heads the Indian Institute of Bank Management, a national banking training institution sponsored and governed by RBI, NABARD, other PSBs, etc. He also serves on the Governing Council of the Centre for Advanced Financial Research and Learning (CAFRAL), Mumbai.
The appointment comes as slice accelerates its mission to build an inclusive and accessible bank, having brought the best of digital banking and UPI to physical branches in Bengaluru and Gurugram in recent months. slice has also started rolling out the much-beloved UPI credit card, bringing credit and rewards that are designed to offer the best experience to all its members. Over the past year, slice has strengthened financial inclusion and regional employment by creating more than 400 new jobs in the Northeast. The bank has also extended its services to new communities, empowering underserved regions with formal banking opportunities and driving long-term economic participation across the Northeast.
"We are privileged to welcome Eugene sir to our Board. His unparalleled expertise in regulatory governance, financial inclusion, and strategic oversight will be invaluable as slice builds on its mission to create India's most loved bank. At a time when we are reimagining banking for millions of Indians, his guidance will help us strengthen our foundation of trust, compliance, and responsible innovation, ensuring that we grow with both ambition and accountability," said Rajan Bajaj, Founder & Executive Director, slice.
"I am excited to join slice at such a pivotal moment in India's banking journey. The opportunity to help build the next generation of banking, rooted in digital-first principles and powered by inclusion, is both a responsibility and a privilege. slice's vision of championing digital banking shows how technology and trust can come together to transform financial access for millions of Indians. I look forward to working closely with the leadership team, and the Board to ensure that this vision is realized with the highest standards of governance and impact," said Mr. Karthak.
About slice:
slice is on a mission to build India's most loved bank. It is reimagining consumer banking in India with simple, transparent, and technology-driven products. Following its merger with North East Small Finance Bank, slice operates as a full-stack bank, offering the slice savings account, slice fixed deposits, slice UPI, slice borrow, slice UPI credit card and India's first UPI-led bank branch. slice's mission is to make banking faster, fairer, accessible and easier for every Indian. slice is backed by marquee global investors such as Tiger Global, Insight Partners, Advent International, Blume Ventures, and Gunosy Capital.
Photo: <a href="https://mma.prnewswire.com/media/2762213/Eugene_Emmanuel_Karthak_slice.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2762213/Eugene_Emmanuel_Karthak_slice.jpg</a>
 
<img title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN63060&sd=2025-09-02"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/in/news-releases/slice-strengthens-board-with-former-rbi-executive-302543507.html" target="_blank">https://www.prnewswire.com/in/news-releases/slice-strengthens-board-with-former-rbi-executive-302543507.html</a>
 <img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN63060&Transmission_Id=202509020224PR_NEWS_EURO_ND__EN63060&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>
The post <a rel="nofollow" href="https://dailyindianews.com/slice-strengthens-board-with-former-rbi-executive/2025/377543/">slice strengthens board with former RBI executive</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="144" src="https://dailyindianews.com/wp-content/uploads/2025/09/slice-strengthens-board-with-former-rbi-executive.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://dailyindianews.com/wp-content/uploads/2025/09/slice-strengthens-board-with-former-rbi-executive.jpg 144w, https://dailyindianews.com/wp-content/uploads/2025/09/slice-strengthens-board-with-former-rbi-executive-100x100.jpg 100w" sizes="auto, (max-width: 144px) 100vw, 144px" /></div>BENGALURU, India, Sept. 2, 2025 /PRNewswire/ — slice, which aims to build India’s most loved bank, has appointed Eugene Emmanuel Karthak, a former Executive Director at the Reserve Bank of India, as Part-time Chairman and Independent Director to its Bank Board.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" src="https://mma.prnewswire.com/media/2762213/Eugene_Emmanuel_Karthak_slice.jpg" title="Eugene Emmanuel Karthak, Part-time Chairman and Independent Director, slice" alt="Eugene Emmanuel Karthak, Part-time Chairman and Independent Director, slice"></img> 
</div>
Mr. Karthak previously served on the board of slice’s parent company Garagepreneurs Internet Private Limited (GIPL) before its banking merger and his continuation with the bank shows stability during a critical growth phase for the company.
With over three decades at India’s central bank, Mr. Karthak led the Information Technology and Corporate Services departments, etc, and also served as Regional Director in RBI Delhi and Bengaluru, where he strengthened regulatory compliance and policy implementation across multiple institutions. He also participated in several high-level RBI committees throughout his tenure.
His governance experience extends to prior board positions at Andhra Bank as RBI Nominee Director and Jana Small Finance Bank as Independent Director. He currently heads the Indian Institute of Bank Management, a national banking training institution sponsored and governed by RBI, NABARD, other PSBs, etc. He also serves on the Governing Council of the Centre for Advanced Financial Research and Learning (CAFRAL), Mumbai.
The appointment comes as slice accelerates its mission to build an inclusive and accessible bank, having brought the best of digital banking and UPI to physical branches in Bengaluru and Gurugram in recent months. slice has also started rolling out the much-beloved UPI credit card, bringing credit and rewards that are designed to offer the best experience to all its members. Over the past year, slice has strengthened financial inclusion and regional employment by creating more than 400 new jobs in the Northeast. The bank has also extended its services to new communities, empowering underserved regions with formal banking opportunities and driving long-term economic participation across the Northeast.
“We are privileged to welcome Eugene sir to our Board. His unparalleled expertise in regulatory governance, financial inclusion, and strategic oversight will be invaluable as slice builds on its mission to create India’s most loved bank. At a time when we are reimagining banking for millions of Indians, his guidance will help us strengthen our foundation of trust, compliance, and responsible innovation, ensuring that we grow with both ambition and accountability,” said Rajan Bajaj, Founder & Executive Director, slice.
“I am excited to join slice at such a pivotal moment in India’s banking journey. The opportunity to help build the next generation of banking, rooted in digital-first principles and powered by inclusion, is both a responsibility and a privilege. slice’s vision of championing digital banking shows how technology and trust can come together to transform financial access for millions of Indians. I look forward to working closely with the leadership team, and the Board to ensure that this vision is realized with the highest standards of governance and impact,” said Mr. Karthak.
About slice:
slice is on a mission to build India’s most loved bank. It is reimagining consumer banking in India with simple, transparent, and technology-driven products. Following its merger with North East Small Finance Bank, slice operates as a full-stack bank, offering the slice savings account, slice fixed deposits, slice UPI, slice borrow, slice UPI credit card and India’s first UPI-led bank branch. slice’s mission is to make banking faster, fairer, accessible and easier for every Indian. slice is backed by marquee global investors such as Tiger Global, Insight Partners, Advent International, Blume Ventures, and Gunosy Capital.
Photo: https://mma.prnewswire.com/media/2762213/Eugene_Emmanuel_Karthak_slice.jpg
 
<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN63060&sd=2025-09-02"></img> View original content to download multimedia:https://www.prnewswire.com/in/news-releases/slice-strengthens-board-with-former-rbi-executive-302543507.html
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN63060&Transmission_Id=202509020224PR_NEWS_EURO_ND__EN63060&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Daily India News takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/slice-strengthens-board-with-former-rbi-executive/2025/377543/">slice strengthens board with former RBI executive</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>Carbon-Negative Plastics Market Size to Hit USD 5.95 billion by 2032, Driven by Rising Adoption in Sustainable Packaging | SNS Insider</title>
<link>https://dailyindianews.com/carbon-negative-plastics-market-size-to-hit-usd-5-95-billion-by-2032-driven-by-rising-adoption-in-sustainable-packaging-sns-insider/2025/377547/</link>
<dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
<pubDate>Tue, 02 Sep 2025 06:00:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/carbon-negative-plastics-market-size-to-hit-usd-5-95-billion-by-2032-driven-by-rising-adoption-in-sustainable-packaging-sns-insider</guid>
<description><![CDATA[The U.S Carbon-Negative Plastics Market size was USD 386 million in 2024 and is expected to reach USD 765 million by 2032 and grow at a CAGR of 8.93% over the forecast period of 2025-2032. Austin, Sept. 02, 2025 (GLOBE NEWSWIRE) — Carbon-Negative Plastics Market Size & Growth Insights: According to the SNS Insider,“The Carbon-Negative Plastics Market Size […]
The post <a rel="nofollow" href="https://dailyindianews.com/carbon-negative-plastics-market-size-to-hit-usd-5-95-billion-by-2032-driven-by-rising-adoption-in-sustainable-packaging-sns-insider/2025/377547/">Carbon-Negative Plastics Market Size to Hit USD 5.95 billion by 2032, Driven by Rising Adoption in Sustainable Packaging | SNS Insider</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[The U.S Carbon-Negative Plastics Market size was USD 386 million in 2024 and is expected to reach USD 765 million by 2032 and grow at a CAGR of 8.93% over the forecast period of 2025-2032.
Austin, Sept. 02, 2025 (GLOBE NEWSWIRE) — Carbon-Negative Plastics Market Size & Growth Insights:
According to the SNS Insider,“The Carbon-Negative Plastics Market Size was valued at USD 3.05 billion in 2024 and is expected to reach USD 5.95 billion by 2032, growing at a CAGR of 8.69% over the forecast period of 2025-2032.”
Global push for sustainability and innovations in carbon capture technologies accelerates the adoption of carbon-negative plastics across diverse industries worldwide.
The Carbon-Negative Plastics Market is expanding as industries embrace sustainability and carbon-neutral solutions. Government mandates such as the European Commission’s Circular Economy Action Plan and the U.S. EPA waste reduction initiatives are encouraging the adoption of eco-friendly alternatives. Companies like TotalEnergies Corbion are scaling bioplastic production, while brands such as Coca-Cola and Unilever are piloting carbon-captured polyethylene bottles. With advancements in carbon capture integration, renewable feedstocks, and growing consumer awareness, carbon-negative plastics are emerging as a vital enabler of climate goals and circular economy transitions.
The US Carbon-Negative Plastics Market is expanding due to government-led sustainability initiatives and rising corporate commitments toward net-zero targets. According to the U.S. Environmental Protection Agency (EPA), packaging waste accounts for nearly 40% of municipal solid waste, prompting companies like PepsiCo and Danimer Scientific to scale PLA-based and PHA-based plastics. Consumer demand for sustainable goods and state-level bans on single-use plastics are accelerating market growth.
Get a Sample Report of Carbon-Negative Plastics Market Forecast @ https://www.snsinsider.com/sample-request/8031 
<img loading="lazy" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=fa5148bd-8057-41f1-952b-02930027ea61&size=0" data-mce-style="display: block; margin-left: auto; margin-right: auto;" data-state="draft" height="400" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/fa5148bd-8057-41f1-952b-02930027ea61/carbon-negative-plastics-market.jpg" style="display:block; margin-left:auto; margin-right:auto;" title="Carbon-negative-Plastics-Market.jpg" width="600" />
Leading Market Players with their Product Listed in this Report are:
<ul>
<li style="text-align:left;">Novomer</li>
<li style="text-align:left;">LanzaTech</li>
<li style="text-align:left;">Newlight Technologies</li>
<li style="text-align:left;">Origin Materials</li>
<li style="text-align:left;">Avantium</li>
<li style="text-align:left;">Bluepha</li>
<li style="text-align:left;">Mango Materials</li>
<li style="text-align:left;">NatureWorks</li>
<li style="text-align:left;">Danimer Scientific</li>
<li style="text-align:left;">RWDC Industries</li>
<li style="text-align:left;">Bio-on</li>
<li style="text-align:left;">Genomatica</li>
<li style="text-align:left;">Full Cycle Bioplastics</li>
<li style="text-align:left;">Borealis</li>
<li style="text-align:left;">PTT MCC Biochem</li>
<li style="text-align:left;">BASF</li>
<li style="text-align:left;">Total Corbion PLA</li>
<li style="text-align:left;">Solvay</li>
<li style="text-align:left;">Yield10 Bioscience</li>
<li style="text-align:left;">Braskem</li>
</ul>
Carbon-Negative Plastics Market Report Scope:
<table style="border-collapse: collapse; margin-left:auto; margin-right:auto; border-collapse:collapse ;">
<tr>
<td style="width:301.34px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Report Attributes</td>
<td style="width:301.34px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Details</td>
</tr>
<tr>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Market Size in 2024</td>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">USD 3.05 Billion</td>
</tr>
<tr>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Market Size by 2032</td>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">USD 5.95 Billion</td>
</tr>
<tr>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">CAGR</td>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">CAGR of 8.69% From 2025 to 2032</td>
</tr>
<tr>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Report Scope & Coverage</td>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook</td>
</tr>
<tr>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Key Segmentation</td>
<td style="width:301.34px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">• By Material Type (Polylactic Acid (PLA), Polyhydroxyalkanoates (PHA), Starch Blends, Carbon-Captured Polyethylene (CC-PE), Others (e.g., CO₂-derived polyurethanes, lignin-based plastics) • By Production Technology (Carbon Capture and Utilization (CCU), Microbial Fermentation, Chemical Synthesis (Catalytic/Enzymatic Conversion), Bio-based Polymerization, Others (e.g., Electrochemical Reduction) • By Application (Packaging, Automotive Components, Consumer Goods, Construction Materials, Textiles & Fibers, Electronics & Electrical, Others (e.g., Agricultural Films, Medical Devices) • By End-Use Industry (Food & Beverage, Retail & E-commerce, Automotive & Transportation, Healthcare, Construction, Electronics, Others (e.g., Fashion, Industrial Use)</td>
</tr>
</table>
Purchase Single User PDF of Carbon-Negative Plastics Market Report (20% Discount) @ https://www.snsinsider.com/checkout/8031 
Key Industry Segmentation
By Material Type, the Polylactic Acid (PLA) dominated the Carbon-Negative Plastics Market in 2024, with a 34.20% Market Share.
The dominance is due to Polylactic Acid’s (PLA) cost-competitiveness, compostability, and wide use in packaging, textiles, and consumer goods. Companies like NatureWorks have expanded PLA production from renewable corn feedstocks, while European players benefit from supportive government bioplastics mandates. With improved recyclability and mechanical strength, PLA is emerging as the most viable carbon-negative material. Its scalability, regulatory backing, and consumer-driven demand make it the leading choice across industries seeking sustainable alternatives to petroleum-based plastics.
By Application, the Packaging dominated the Carbon-Negative Plastics Market in 2024, with a Major Market Share.
The dominance is due to packaging’s central role in meeting global demand for sustainable and recyclable solutions. The U.S. Plastics Pact (2023) committed leading companies to ensure all packaging becomes reusable, recyclable, or compostable by 2025. Food and beverage giants are transitioning toward PLA, starch blends, and carbon-captured polyethylene (CC-PE) packaging to meet sustainability pledges and consumer expectations. Strong environmental regulations, brand commitments, and rising awareness of waste reduction position packaging as the most influential application for carbon-negative plastics.
By Region, Europe dominated the Carbon-Negative Plastics Market in 2024, Holding A 42.70% Market Share. 
The dominance is due to Europe’s strong environmental policies, consumer demand, and rapid adoption of sustainable plastics. The European Union’s Plastics Strategy and bans on single-use plastics have accelerated the shift toward bio-based and carbon-captured plastics. Countries like Germany and France have heavily invested in PLA packaging, while Scandinavian nations lead in circular economy practices. Government-backed projects, strong R&D capabilities, and corporate sustainability commitments make Europe the most advanced hub for scaling carbon-negative plastics and driving global market momentum.
Do you have any specific queries or need any customized research on Carbon-Negative Plastics Market? Submit your inquiry here @ https://www.snsinsider.com/enquiry/8031
USPs of the Carbon-Negative Plastics Market Report
<ul>
<li style="text-align:left;">CARBON FOOTPRINT REDUCTION BY MATERIAL TYPE – Demonstrating how each material’s lifecycle emissions compare, helping clients identify the most climate-friendly options.</li>
</ul>
<ul>
<li style="text-align:left;">END-OF-LIFE DISPOSAL & RECYCLING STATISTICS – Highlights recyclability or compostability rates to support sustainability claims and end-user communications.</li>
</ul>
<ul>
<li style="text-align:left;">POLICY INCENTIVES AND SUBSIDY BENCHMARKS – Illustrates financial support available, aiding clients in planning investments and anticipating cost-offsets.</li>
</ul>
<ul>
<li style="text-align:left;">SUPPLY CHAIN EMISSION INTENSITY DATA – Quantifies emissions per production stage, offering clients transparency and an improvement roadmap.</li>
</ul>
<ul>
<li style="text-align:left;">COST-PER-UNIT COMPARISON WITH TRADITIONAL PLASTICS – Helps clients benchmark price competitiveness and drive procurement decisions.</li>
</ul>
<ul>
<li style="text-align:left;">CONSUMER WILLINGNESS-TO-PAY SURVEYS – Reveals premium pricing tolerance, supporting pricing strategies and value justification.</li>
</ul>
<ul>
<li style="text-align:left;">PATENT AND INNOVATION ACTIVITY METRICS – Tracks filings, signifying research momentum and competitive edge potential.</li>
</ul>
Recent Developments
<ul>
<li style="text-align:left;">In Jun 2025, Teknor Apex announced the acquisition of Danimer Scientific to broaden its sustainable materials portfolio and scale PHA resin commercialization.</li>
<li style="text-align:left;">In March 2025, NatureWorks introduced Ingeo Extend 4950D, a new PLA grade designed to improve film production efficiency (BOPLA) and lower production costs for filmmakers. </li>
</ul>
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
<pre>CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)</pre>
<img alt="" src='https://ml.globenewswire.com/media/NjI2OTMzMDktYTVjZC00ZmFmLWJhNGMtMTlhNjk4NzNhNzEwLTEyNjg4MTktMjAyNS0wOS0wMi1lbg==/tiny/SNS-Insider-pvt-ltd.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/carbon-negative-plastics-market-size-to-hit-usd-5-95-billion-by-2032-driven-by-rising-adoption-in-sustainable-packaging-sns-insider/2025/377547/">Carbon-Negative Plastics Market Size to Hit USD 5.95 billion by 2032, Driven by Rising Adoption in Sustainable Packaging | SNS Insider</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>Diageo India Breaks Ground on The Good Craft Co. Flavour Market in Ponda, Goa</title>
<link>https://dailyindianews.com/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa/2025/377545/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 02 Sep 2025 05:30:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="114" src="https://dailyindianews.com/wp-content/uploads/2025/09/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
A first-of-its-kind space combining a craft making hub, nanobrewery, innovation lab, startup incubator, retail hub and craft experience centre, it's the world's largest destination dedicated to Indian craft beverages
PANAJI, India, Sept. 2, 2025 /PRNewswire/ -- Diageo India has officially broken ground on The Good Craft Co. Flavour Market, the world's largest destination dedicated to Indian craft beverages. Located in Ponda, Goa, at the historic site where India's first single malt was once produced, the new space brings together legacy and innovation in one integrated ecosystem. The project is the latest milestone in Diageo's commitment to fostering craft, culture, and collaboration through its platform, The Good Craft Co. (TGCC).
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <a href="https://mma.prnewswire.com/media/2761940/The_Good_Craft_Co.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2761940/The_Good_Craft_Co.jpg" title="The Good Craft Co. Flavour Market" alt="The Good Craft Co. Flavour Market"></img> </a> 
</div>
TGCC Flavour Market: A Groundbreaking Destination for Indian Craft 
Spread across a lush 11 acres amidst Goa's forests, this dynamic space is equal parts craft hub, innovation lab, and immersive experience centre. From production to exploration, here is everything one will find at TGCC Flavour Market — a destination being built to explore the full spectrum of Indian craft:
<ul type="disc">
<li>An immersive experience centre and guided tours</li>
<li>A spice walk and botanical trail, highlighting local terroir and ingredients</li>
<li>A vault for rare creations, Ponda will house Diageo India's one-of-a-kind luxury cask programme</li>
<li>A nanobrewery and micro-distillery for innovation and exploration</li>
<li>A startup incubator to support emerging founders and F&B disruptors</li>
<li>A retail destination for bespoke craft liquids</li>
<li>A craft tasting room to showcase seasonal cocktail and food menus, with exciting chef and mixologist collaborations</li>
<li>The Academy — a platform for workshops, mentorship and community, offering certified courses in the beverage space</li>
</ul>
The upcoming site builds on TGCC's broader mission to spotlight the stories, ingredients, and ideas shaping India's contemporary craft movement. It follows the success of TGCC's Flavour Lab in Bangalore — a space that brings the community together through interactive tastings, workshops, and conversations around Indian craft. TGCC Flavour Market in Goa now scales up that vision: a larger, immersive destination where travellers, makers, and curious minds can understand India's craft beverage culture firsthand.
Vikram Damodaran, Chief Innovation Officer, Diageo India, says, "The Good Craft Co. began as a way to spark curiosity and conversations around India's craft movement. The Flavour Lab in Bangalore laid the foundation, but with Ponda, we are building something far more ambitious. It's a dynamic space where different parts of the community can engage with Indian craft in meaningful ways. Whether you are a maker, a chef, an entrepreneur, or just someone who is curious, Ponda has something to offer — and we can't wait to welcome people to experience it for themselves when we open doors. Under one roof, we are bringing together ideas, people and experiences to explore conscious consumption and hone the future of craft. We are excited to see what takes shape here."
The TGCC Flavour Market in Ponda is one more chapter in Diageo India's larger craft vision — from launching Godawan, one of India's most awarded single malts rooted in conservation, to curating cultural experiences that bring mindful luxury and Indian artistry to the forefront, to investing in homegrown brands and platforms that nurture the next wave of craft.
About Diageo India
Diageo India is among India's leading beverage alcohol (alcobev) companies with an outstanding portfolio of premium brands. A subsidiary of Diageo Plc., it is listed in India on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) as United Spirits Limited (USL).
Headquartered in Bengaluru, Diageo India has one of the largest manufacturing footprints in alcobev with 36 facilities across India. It manufactures, sells and distributes Johnnie Walker, Black Dog, Black & White, VAT 69, Antiquity, Signature, The Singleton, Royal Challenge, McDowell's No1, Smirnoff, Ketel One, Tanqueray, Captain Morgan and Godawan, an artisanal single malt whisky from India, bringing together global expertise and local pride to deliver innovative, world-class products and experiences to consumers. With a strong focus on driving a positive impact on society, Diageo India has been working on collective action to improve livelihoods, championing Grain to Glass sustainability, responsible consumption and nurturing the alcobev ecosystem, to contribute to India's growth agenda.
For more information about Diageo India, our people, our brands, and our performance, visit us at <a href="https://www.diageoindia.com/" target="_blank" rel="nofollow">www.diageoindia.com</a>. Visit Diageo's global responsible drinking resource, <a href="http://www.drinkiq.com/" target="_blank" rel="nofollow">http://www.DRINKiQ.com</a>, for information, initiatives, and ways to share best practices.
Celebrating life, every day, everywhere.
Photo: <a href="https://mma.prnewswire.com/media/2761940/The_Good_Craft_Co.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2761940/The_Good_Craft_Co.jpg</a>
 
<img title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN57168&sd=2025-09-02"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/in/news-releases/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa-302543075.html" target="_blank">https://www.prnewswire.com/in/news-releases/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa-302543075.html</a>
 <img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN57168&Transmission_Id=202509020130PR_NEWS_EURO_ND__EN57168&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>
The post <a rel="nofollow" href="https://dailyindianews.com/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa/2025/377545/">Diageo India Breaks Ground on The Good Craft Co. Flavour Market in Ponda, Goa</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="114" src="https://dailyindianews.com/wp-content/uploads/2025/09/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>A first-of-its-kind space combining a craft making hub, nanobrewery, innovation lab, startup incubator, retail hub and craft experience centre, it’s the world’s largest destination dedicated to Indian craft beverages
PANAJI, India, Sept. 2, 2025 /PRNewswire/ — Diageo India has officially broken ground on The Good Craft Co. Flavour Market, the world’s largest destination dedicated to Indian craft beverages. Located in Ponda, Goa, at the historic site where India’s first single malt was once produced, the new space brings together legacy and innovation in one integrated ecosystem. The project is the latest milestone in Diageo’s commitment to fostering craft, culture, and collaboration through its platform, The Good Craft Co. (TGCC).
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" src="https://mma.prnewswire.com/media/2761940/The_Good_Craft_Co.jpg" title="The Good Craft Co. Flavour Market" alt="The Good Craft Co. Flavour Market"></img> 
</div>
TGCC Flavour Market: A Groundbreaking Destination for Indian Craft 
Spread across a lush 11 acres amidst Goa’s forests, this dynamic space is equal parts craft hub, innovation lab, and immersive experience centre. From production to exploration, here is everything one will find at TGCC Flavour Market — a destination being built to explore the full spectrum of Indian craft:
<ul type="disc">
<li>An immersive experience centre and guided tours</li>
<li>A spice walk and botanical trail, highlighting local terroir and ingredients</li>
<li>A vault for rare creations, Ponda will house Diageo India’s one-of-a-kind luxury cask programme</li>
<li>A nanobrewery and micro-distillery for innovation and exploration</li>
<li>A startup incubator to support emerging founders and F&B disruptors</li>
<li>A retail destination for bespoke craft liquids</li>
<li>A craft tasting room to showcase seasonal cocktail and food menus, with exciting chef and mixologist collaborations</li>
<li>The Academy — a platform for workshops, mentorship and community, offering certified courses in the beverage space</li>
</ul>
The upcoming site builds on TGCC’s broader mission to spotlight the stories, ingredients, and ideas shaping India’s contemporary craft movement. It follows the success of TGCC’s Flavour Lab in Bangalore — a space that brings the community together through interactive tastings, workshops, and conversations around Indian craft. TGCC Flavour Market in Goa now scales up that vision: a larger, immersive destination where travellers, makers, and curious minds can understand India’s craft beverage culture firsthand.
Vikram Damodaran, Chief Innovation Officer, Diageo India, says, “The Good Craft Co. began as a way to spark curiosity and conversations around India’s craft movement. The Flavour Lab in Bangalore laid the foundation, but with Ponda, we are building something far more ambitious. It’s a dynamic space where different parts of the community can engage with Indian craft in meaningful ways. Whether you are a maker, a chef, an entrepreneur, or just someone who is curious, Ponda has something to offer — and we can’t wait to welcome people to experience it for themselves when we open doors. Under one roof, we are bringing together ideas, people and experiences to explore conscious consumption and hone the future of craft. We are excited to see what takes shape here.“
The TGCC Flavour Market in Ponda is one more chapter in Diageo India’s larger craft vision — from launching Godawan, one of India’s most awarded single malts rooted in conservation, to curating cultural experiences that bring mindful luxury and Indian artistry to the forefront, to investing in homegrown brands and platforms that nurture the next wave of craft.
About Diageo India
Diageo India is among India’s leading beverage alcohol (alcobev) companies with an outstanding portfolio of premium brands. A subsidiary of Diageo Plc., it is listed in India on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) as United Spirits Limited (USL).
Headquartered in Bengaluru, Diageo India has one of the largest manufacturing footprints in alcobev with 36 facilities across India. It manufactures, sells and distributes Johnnie Walker, Black Dog, Black & White, VAT 69, Antiquity, Signature, The Singleton, Royal Challenge, McDowell’s No1, Smirnoff, Ketel One, Tanqueray, Captain Morgan and Godawan, an artisanal single malt whisky from India, bringing together global expertise and local pride to deliver innovative, world-class products and experiences to consumers. With a strong focus on driving a positive impact on society, Diageo India has been working on collective action to improve livelihoods, championing Grain to Glass sustainability, responsible consumption and nurturing the alcobev ecosystem, to contribute to India’s growth agenda.
For more information about Diageo India, our people, our brands, and our performance, visit us at www.diageoindia.com. Visit Diageo’s global responsible drinking resource, http://www.DRINKiQ.com, for information, initiatives, and ways to share best practices.
Celebrating life, every day, everywhere.
Photo: https://mma.prnewswire.com/media/2761940/The_Good_Craft_Co.jpg
 
<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN57168&sd=2025-09-02"></img> View original content to download multimedia:https://www.prnewswire.com/in/news-releases/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa-302543075.html
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN57168&Transmission_Id=202509020130PR_NEWS_EURO_ND__EN57168&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Daily India News takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/diageo-india-breaks-ground-on-the-good-craft-co-flavour-market-in-ponda-goa/2025/377545/">Diageo India Breaks Ground on The Good Craft Co. Flavour Market in Ponda, Goa</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>GGVL Relaunches V21 in 100% Recycled PET — India’s First Beverage Brand to Do So</title>
<link>https://dailyindianews.com/ggvl-relaunches-v21-in-100-recycled-pet-indias-first-beverage-brand-to-do-so/2025/377541/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 02 Sep 2025 04:30:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/ggvl-relaunches-v21-in-100-recycled-pet-indias-first-beverage-brand-to-do-so</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="96" height="144" src="https://dailyindianews.com/wp-content/uploads/2025/09/ggvl-relaunches-v21-in-100-recycled-pet-indias-first-beverage-brand-to-do-so.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
From turning waste into want, to reshaping what premium looks like — Great Galleon Ventures Limited sets a new benchmark in packaging & sustainability Each bottle of V21 in rPET saves 70 litres of water, 46.6 energy units, and 1.7 kg of CO₂ compared to virgin PET — enough impact to meet the daily water needs of 2.5 lakh people, power over 3.2 lakh homes, and offset emissions equal to 3 million trees working in one day This new packaging format can move the wider beverage industry toward circular packaging, reducing solid waste by 42%
INDORE, India, Sept. 2, 2025 /PRNewswire/ -- For decades, Great Galleon Ventures Limited (GGVL) has been powering India's consumer goods ecosystem as a trusted manufacturing partner to global companies. But now, this zero-waste, Madhya Pradesh-based organisation is stepping forward with something to say — and it's doing so with a bottle that could change how the industry thinks about packaging.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <a href="https://mma.prnewswire.com/media/2761883/GGVL_V21_Relaunch.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2761883/GGVL_V21_Relaunch.jpg" title="Great Galleon Ventures Limited" alt="Great Galleon Ventures Limited"></img> </a> 
</div>
GGVL this month has relaunched its homegrown brand, V21, in 100% rPET (Recycled Polyethylene Terephthalate) — making it one of the first Indian beverage brands to use certified, food-grade recycled plastic. In a world where glass still dominates the perception of 'premium', this bottle proves that sustainability can be smart, stylish, and scalable.
A bottle that turns waste into want: The new V21 comes in a sleek 180ml flask — lightweight, shatterproof, and designed for modern, on-the-go lifestyles. But here's what makes it different:
<ul type="disc">
<li>100% rPET: made entirely from post-consumer plastic waste, recycled and certified food-grade.</li>
<li>Durable and portable: no risk of breakage, great for travel and everyday use.</li>
<li>Lower carbon footprint: drastically reduces environmental impact compared to virgin PET.</li>
<li>Every production cycle of V21 in rPET saves over 5.7 million litres of water, the equivalent energy of powering Chandigarh for a day, and prevents 138.7 tonnes of CO₂ emissions.</li>
</ul>
This move comes at a time when India generates approximately 3.4 million tonnes of plastic waste every year, with less than 30% effectively recycled. By shifting to rPET, GGVL is demonstrating how circular packaging can reduce solid waste by 42% while setting a precedent for India's consumer packaging industry.
V21's liquid remains unchanged — triple-distilled, silver-filtered, and smooth on the palate — offered in Original, Green Apple, and Orange. But the experience around it is completely reimagined. GGVL observed how younger drinkers were already embracing PET in 180ml formats — not out of compromise, but culture. These bottles have become a symbol of casual gatherings, travel, and spontaneity. Globally, rPET adoption has grown by <a href="https://www.euromonitor.com/article/top-trends-shaping-pet-bottle-packaging-demand?utm_source=chatgpt.com" target="_blank" rel="nofollow">45% year-on-year among beverage companies,</a> a signal that environmental innovation is not just good optics. With V21, that behaviour is met with more intention.
"This isn't a one-off. We asked ourselves — what if the future of beverages wasn't just about better liquid, but smarter choices? That question is closely aligned with how today's consumers, especially Gen Z and millennials, are thinking. 62%+ of Indian consumers say they prefer brands with clear sustainability commitments. The relaunch of V21 is part of our broader sustainability charter, Bold Planet, which is driving real, systemic change across our portfolio — from eliminating mono-cartons on our premium products to investing in sustainable inks, recycled label papers, and circular production models. The goal isn't to retrofit sustainability onto a product — it's to design for it from the very beginning. And we're excited to lead that shift," says Utsav Kedia, Vice President – Business Growth, Great Galleon Ventures Limited.
For a company that began its journey in 1969 — pioneering premium manufacturing in Madhya Pradesh and introducing new formats to the Indian market — GGVL has always been engineered for tomorrow. The relaunch of V21 is an invitation — to rethink, redesign, and reimagine what premium can look like when purpose is part of the pour.
Availability: Madhya Pradesh Price: INR 220 per 180ml SKU of rPET ABV: 40%
About Great Galleon Ventures Ltd. (GGVL)
Founded in 1985, GGVL is an Indian company that specialises in bottle manufacturing, ENA and ethanol production, contract manufacturing, and premium beverage innovation. The company is known for its credibility, quality, and bold innovation. With brands like V21, Rascal RTDs and Bigg Bull, GGVL is shaping the future of responsible consumer packaging in India. For more information, please visit the <a href="https://www.greatgalleon.com/" target="_blank" rel="nofollow">website</a>.
Photo: <a href="https://mma.prnewswire.com/media/2761883/GGVL_V21_Relaunch.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2761883/GGVL_V21_Relaunch.jpg</a>
 
<img title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN62738&sd=2025-09-02"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/in/news-releases/ggvl-relaunches-v21-in-100-recycled-pet--indias-first-beverage-brand-to-do-so-302543429.html" target="_blank">https://www.prnewswire.com/in/news-releases/ggvl-relaunches-v21-in-100-recycled-pet--indias-first-beverage-brand-to-do-so-302543429.html</a>
 <img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN62738&Transmission_Id=202509020030PR_NEWS_EURO_ND__EN62738&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>
The post <a rel="nofollow" href="https://dailyindianews.com/ggvl-relaunches-v21-in-100-recycled-pet-indias-first-beverage-brand-to-do-so/2025/377541/">GGVL Relaunches V21 in 100% Recycled PET — India’s First Beverage Brand to Do So</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="96" height="144" src="https://dailyindianews.com/wp-content/uploads/2025/09/ggvl-relaunches-v21-in-100-recycled-pet-indias-first-beverage-brand-to-do-so.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>From turning waste into want, to reshaping what premium looks like — Great Galleon Ventures Limited sets a new benchmark in packaging & sustainability Each bottle of V21 in rPET saves 70 litres of water, 46.6 energy units, and 1.7 kg of CO₂ compared to virgin PET — enough impact to meet the daily water needs of 2.5 lakh people, power over 3.2 lakh homes, and offset emissions equal to 3 million trees working in one day This new packaging format can move the wider beverage industry toward circular packaging, reducing solid waste by 42%
INDORE, India, Sept. 2, 2025 /PRNewswire/ — For decades, Great Galleon Ventures Limited (GGVL) has been powering India’s consumer goods ecosystem as a trusted manufacturing partner to global companies. But now, this zero-waste, Madhya Pradesh-based organisation is stepping forward with something to say — and it’s doing so with a bottle that could change how the industry thinks about packaging.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" src="https://mma.prnewswire.com/media/2761883/GGVL_V21_Relaunch.jpg" title="Great Galleon Ventures Limited" alt="Great Galleon Ventures Limited"></img> 
</div>
GGVL this month has relaunched its homegrown brand, V21, in 100% rPET (Recycled Polyethylene Terephthalate) — making it one of the first Indian beverage brands to use certified, food-grade recycled plastic. In a world where glass still dominates the perception of ‘premium’, this bottle proves that sustainability can be smart, stylish, and scalable.
A bottle that turns waste into want: The new V21 comes in a sleek 180ml flask — lightweight, shatterproof, and designed for modern, on-the-go lifestyles. But here’s what makes it different:
<ul type="disc">
<li>100% rPET: made entirely from post-consumer plastic waste, recycled and certified food-grade.</li>
<li>Durable and portable: no risk of breakage, great for travel and everyday use.</li>
<li>Lower carbon footprint: drastically reduces environmental impact compared to virgin PET.</li>
<li>Every production cycle of V21 in rPET saves over 5.7 million litres of water, the equivalent energy of powering Chandigarh for a day, and prevents 138.7 tonnes of CO₂ emissions.</li>
</ul>
This move comes at a time when India generates approximately 3.4 million tonnes of plastic waste every year, with less than 30% effectively recycled. By shifting to rPET, GGVL is demonstrating how circular packaging can reduce solid waste by 42% while setting a precedent for India’s consumer packaging industry.
V21’s liquid remains unchanged — triple-distilled, silver-filtered, and smooth on the palate — offered in Original, Green Apple, and Orange. But the experience around it is completely reimagined. GGVL observed how younger drinkers were already embracing PET in 180ml formats — not out of compromise, but culture. These bottles have become a symbol of casual gatherings, travel, and spontaneity. Globally, rPET adoption has grown by 45% year-on-year among beverage companies, a signal that environmental innovation is not just good optics. With V21, that behaviour is met with more intention.
“This isn’t a one-off. We asked ourselves — what if the future of beverages wasn’t just about better liquid, but smarter choices? That question is closely aligned with how today’s consumers, especially Gen Z and millennials, are thinking. 62%+ of Indian consumers say they prefer brands with clear sustainability commitments. The relaunch of V21 is part of our broader sustainability charter, Bold Planet, which is driving real, systemic change across our portfolio — from eliminating mono-cartons on our premium products to investing in sustainable inks, recycled label papers, and circular production models. The goal isn’t to retrofit sustainability onto a product — it’s to design for it from the very beginning. And we’re excited to lead that shift,” says Utsav Kedia, Vice President – Business Growth, Great Galleon Ventures Limited.
For a company that began its journey in 1969 — pioneering premium manufacturing in Madhya Pradesh and introducing new formats to the Indian market — GGVL has always been engineered for tomorrow. The relaunch of V21 is an invitation — to rethink, redesign, and reimagine what premium can look like when purpose is part of the pour.
Availability: Madhya Pradesh Price: INR 220 per 180ml SKU of rPET ABV: 40%
About Great Galleon Ventures Ltd. (GGVL)
Founded in 1985, GGVL is an Indian company that specialises in bottle manufacturing, ENA and ethanol production, contract manufacturing, and premium beverage innovation. The company is known for its credibility, quality, and bold innovation. With brands like V21, Rascal RTDs and Bigg Bull, GGVL is shaping the future of responsible consumer packaging in India. For more information, please visit the website.
Photo: https://mma.prnewswire.com/media/2761883/GGVL_V21_Relaunch.jpg
 
<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN62738&sd=2025-09-02"></img> View original content to download multimedia:https://www.prnewswire.com/in/news-releases/ggvl-relaunches-v21-in-100-recycled-pet–indias-first-beverage-brand-to-do-so-302543429.html
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN62738&Transmission_Id=202509020030PR_NEWS_EURO_ND__EN62738&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Daily India News takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/ggvl-relaunches-v21-in-100-recycled-pet-indias-first-beverage-brand-to-do-so/2025/377541/">GGVL Relaunches V21 in 100% Recycled PET — India’s First Beverage Brand to Do So</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>India’s Gaming Reset: New Law Sparks a Turning Point for the Industry, Says Redseer Strategy Consultants</title>
<link>https://dailyindianews.com/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants/2025/377539/</link>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 02 Sep 2025 04:30:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants</guid>
<description><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="51" src="https://dailyindianews.com/wp-content/uploads/2025/09/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>
BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- With over 500 million digital gamers in CY2024, India was on track to become one of the world's largest gaming hubs. But the recent passing of the 'Promotion and Regulation of Online Gaming 2025' bill on 22 August marks a watershed moment. The law prohibits real money gaming (RMG) while formally recognising eSports as a competitive sport, setting the stage for a massive industry pivot.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <a href="https://mma.prnewswire.com/media/2760913/5483428/Redseer_Strategy_Consultants_Logo.html" target="_blank" rel="nofollow"> <img src="https://mma.prnewswire.com/media/2760913/5483428/Redseer_Strategy_Consultants_Logo.jpg" title="Redseer Strategy Consultants Logo (PRNewsfoto/Redseer Strategy Consultants)" alt="Redseer Strategy Consultants Logo (PRNewsfoto/Redseer Strategy Consultants)"></img> </a> 
</div>
The immediate impact is stark. According to Redseer's <a href="https://redseer.com/articles/indias-gaming-story-after-rmg-prohibition-3-themes-that-will-define-the-short-to-mid-term/?utm_source=PR&utm_medium=PR-Newswire&utm_campaign=RMG" target="_blank" rel="nofollow">recent report</a>, RMG, which had 80–100 million annual users and was projected to grow at 12–15% CAGR, has come to a halt. Beyond gaming platforms, dependent sectors such as digital advertising, sponsorships, and payments infrastructure have also been hit. Yet, amid this disruption, three new growth engines are emerging.
Casual gaming and eSports are positioned as the next frontier. Rising paid user bases, higher ARPPU (growing from $2–5 in 2020 to $25–30 in 2024), and government recognition are driving momentum. India's eSports market, currently ~$40 Mn, is projected to expand at 30–35% CAGR, as brands ramp up engagement with younger demographics and publishers invest in mass-market titles.
Industry adjacencies and global expansion are opening new doors. Former RMG players are exploring adjacent categories such as OTT, merchandise, sports ticketing, analytics, and gamification projects. International expansion also remains attractive, especially by popularising Indian-origin titles and sports.
"For India's gaming sector, this is both a challenge and an opportunity. As companies reset their models, while a few operators plan to challenge the bill, the winners will be those who innovate fast, whether in casual formats, eSports ecosystems, or global expansion," said Mukesh Kumar, Associate Partner at Redseer Strategy Consultants.
The next few years will test the resilience and agility of India's gaming ecosystem. But with a massive gamer base, surging demand, and policy support for non-RMG formats, India is poised to script a new growth story in global gaming.
About Redseer
Redseer Strategy Consultants is a leading strategy consulting firm, solving the strategy behind scale for brands and new-age companies. Headquartered in Bengaluru, Redseer has 200+ consultants across India, ME, and SEA. Learn more: <a href="http://www.redseer.com/" target="_blank" rel="nofollow">www.redseer.com</a>
Media Contact
Aanshul A Agarwal <a href="mailto:media@redseerconsulting.com" target="_blank" rel="nofollow">media@redseerconsulting.com</a> 
Logo: <a href="https://mma.prnewswire.com/media/2760913/Redseer_Strategy_Consultants_Logo.jpg" target="_blank" rel="nofollow">https://mma.prnewswire.com/media/2760913/Redseer_Strategy_Consultants_Logo.jpg</a>
 
<img title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN61892&sd=2025-09-02"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/in/news-releases/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants-302542135.html" target="_blank">https://www.prnewswire.com/in/news-releases/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants-302542135.html</a>
 <img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN61892&Transmission_Id=202509020030PR_NEWS_EURO_ND__EN61892&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>
The post <a rel="nofollow" href="https://dailyindianews.com/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants/2025/377539/">India’s Gaming Reset: New Law Sparks a Turning Point for the Industry, Says Redseer Strategy Consultants</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[<div style="margin-bottom:20px;"><img width="144" height="51" src="https://dailyindianews.com/wp-content/uploads/2025/09/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" /></div>BENGALURU, India, Sept. 2, 2025 /PRNewswire/ — With over 500 million digital gamers in CY2024, India was on track to become one of the world’s largest gaming hubs. But the recent passing of the ‘Promotion and Regulation of Online Gaming 2025‘ bill on 22 August marks a watershed moment. The law prohibits real money gaming (RMG) while formally recognising eSports as a competitive sport, setting the stage for a massive industry pivot.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 <img decoding="async" src="https://mma.prnewswire.com/media/2760913/5483428/Redseer_Strategy_Consultants_Logo.jpg" title="Redseer Strategy Consultants Logo (PRNewsfoto/Redseer Strategy Consultants)" alt="Redseer Strategy Consultants Logo (PRNewsfoto/Redseer Strategy Consultants)"></img> 
</div>
The immediate impact is stark. According to Redseer’s recent report, RMG, which had 80–100 million annual users and was projected to grow at 12–15% CAGR, has come to a halt. Beyond gaming platforms, dependent sectors such as digital advertising, sponsorships, and payments infrastructure have also been hit. Yet, amid this disruption, three new growth engines are emerging.
Casual gaming and eSports are positioned as the next frontier. Rising paid user bases, higher ARPPU (growing from $2–5 in 2020 to $25–30 in 2024), and government recognition are driving momentum. India’s eSports market, currently ~$40 Mn, is projected to expand at 30–35% CAGR, as brands ramp up engagement with younger demographics and publishers invest in mass-market titles.
Industry adjacencies and global expansion are opening new doors. Former RMG players are exploring adjacent categories such as OTT, merchandise, sports ticketing, analytics, and gamification projects. International expansion also remains attractive, especially by popularising Indian-origin titles and sports.
“For India’s gaming sector, this is both a challenge and an opportunity. As companies reset their models, while a few operators plan to challenge the bill, the winners will be those who innovate fast, whether in casual formats, eSports ecosystems, or global expansion,” said Mukesh Kumar, Associate Partner at Redseer Strategy Consultants.
The next few years will test the resilience and agility of India’s gaming ecosystem. But with a massive gamer base, surging demand, and policy support for non-RMG formats, India is poised to script a new growth story in global gaming.
About Redseer
Redseer Strategy Consultants is a leading strategy consulting firm, solving the strategy behind scale for brands and new-age companies. Headquartered in Bengaluru, Redseer has 200+ consultants across India, ME, and SEA. Learn more: www.redseer.com
Media Contact
Aanshul A Agarwal media@redseerconsulting.com 
Logo: https://mma.prnewswire.com/media/2760913/Redseer_Strategy_Consultants_Logo.jpg
 
<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=EN61892&sd=2025-09-02"></img> View original content to download multimedia:https://www.prnewswire.com/in/news-releases/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants-302542135.html
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=EN61892&Transmission_Id=202509020030PR_NEWS_EURO_ND__EN61892&DateId=20250902" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Daily India News takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/indias-gaming-reset-new-law-sparks-a-turning-point-for-the-industry-says-redseer-strategy-consultants/2025/377539/">India’s Gaming Reset: New Law Sparks a Turning Point for the Industry, Says Redseer Strategy Consultants</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>Bone Marrow Failure Market Growth Accelerates with Advances in Cell and Gene Therapy | DelveInsight</title>
<link>https://dailyindianews.com/bone-marrow-failure-market-growth-accelerates-with-advances-in-cell-and-gene-therapy-delveinsight/2025/377523/</link>
<dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
<pubDate>Mon, 01 Sep 2025 17:00:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/bone-marrow-failure-market-growth-accelerates-with-advances-in-cell-and-gene-therapy-delveinsight</guid>
<description><![CDATA[The bone marrow failure market is witnessing steady growth driven by the increasing prevalence of aplastic anemia, myelodysplastic syndromes, and other related disorders. Advancements in stem cell transplantation, gene therapy, and immunosuppressive treatments are expanding therapeutic options and improving patient outcomes. Rising awareness, better diagnostic techniques, and supportive government initiatives are further fueling demand. New […]
The post <a rel="nofollow" href="https://dailyindianews.com/bone-marrow-failure-market-growth-accelerates-with-advances-in-cell-and-gene-therapy-delveinsight/2025/377523/">Bone Marrow Failure Market Growth Accelerates with Advances in Cell and Gene Therapy | DelveInsight</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[The bone marrow failure market is witnessing steady growth driven by the increasing prevalence of aplastic anemia, myelodysplastic syndromes, and other related disorders. Advancements in stem cell transplantation, gene therapy, and immunosuppressive treatments are expanding therapeutic options and improving patient outcomes. Rising awareness, better diagnostic techniques, and supportive government initiatives are further fueling demand.
New York, USA, Sept. 01, 2025 (GLOBE NEWSWIRE) — Bone Marrow Failure Market Growth Accelerates with Advances in Cell and Gene Therapy | DelveInsight
The bone marrow failure market is witnessing steady growth driven by the increasing prevalence of aplastic anemia, myelodysplastic syndromes, and other related disorders. Advancements in stem cell transplantation, gene therapy, and immunosuppressive treatments are expanding therapeutic options and improving patient outcomes. Rising awareness, better diagnostic techniques, and supportive government initiatives are further fueling demand.
DelveInsight’s Bone Marrow Failure Market Insights report includes a comprehensive understanding of current treatment practices, emerging bone marrow failure drugs, market share of individual therapies, and current and forecasted bone marrow failure market size from 2020 to 2034, segmented into leading markets (the US, EU4, UK, and Japan).
Bone Marrow Failure Market Summary
<ul type="disc">
<li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">According to DelveInsight’s analysis, the total bone marrow failure treatment market size is expected to grow positively by 2034 in the leading markets (the US, EU4, UK, and Japan).</li>
</ul>
<ul type="disc">
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">The United States accounts for the largest market size of Bone Marrow Failure, in comparison to EU4 (Germany, Italy, France, and Spain) and the UK, and Japan.</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Bone marrow failure incidence rate is 2 per million in Europe, with higher rates in Asia, perhaps resulting from environmental factors.</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Key bone marrow failure companies, including Elixirgen Therapeutics, Cellenkos, and others, are actively working on innovative bone marrow failure drugs. </li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Some of the key bone marrow failure therapies in clinical trials include EXG34217, CK0801, and others. These novel bone marrow failure therapies are anticipated to enter the bone marrow failure market in the forecast period and are expected to change the market.</li>
</ul>
Discover which bone marrow failure medications are expected to grab the market share @ Bone Marrow Failure Market Report
Key Factors Driving the Growth of the Bone Marrow Failure Market 
Rising Prevalence and Incidence of Bone Marrow Failure Disorders
The increasing number of patients diagnosed with bone marrow failure syndromes is a primary growth driver. Aging populations, greater recognition of inherited bone marrow disorders, and higher survival rates of patients with prior cancer treatments are contributing to the expansion of the market. The 5-year survival rates were 90.7% in patients aged 0–18 years, 90.5% in patients aged 19–39 years, 70.7% in patients aged 40–59 years, and 38.1% in patients aged 60 years or older.
Advancements in Treatment Modalities
Therapeutic innovation is reshaping the treatment landscape. The development of targeted therapies, gene therapy, hematopoietic stem cell transplantation (HSCT) techniques, and immunomodulatory drugs has improved survival outcomes. Novel agents addressing underlying molecular mechanisms are attracting investment and accelerating bone marrow failure market growth.
Growing Stem Cell Transplantation Procedures
Stem cell transplantation remains the only curative option for many bone marrow failure conditions. Expanding transplantation infrastructure, wider donor registries, and improved conditioning regimens are enabling greater adoption. Emerging approaches, such as haploidentical transplantation and cord blood use, are broadening accessibility to a larger patient pool.
Increased Research and Bone Marrow Failure Clinical Trials
The pipeline for bone marrow failure treatments is expanding, with ongoing clinical trials evaluating innovative agents, including complement inhibitors, TPO receptor agonists, and gene-editing technologies. Currently, the therapies in clinical trials for bone marrow failure include EXG34217 (Elixirgen Therapeutics), CK0801 (Cellenkos), and others.
Rising Awareness and Early Diagnosis
Public health initiatives, patient advocacy groups, and physician education are leading to earlier recognition of symptoms such as unexplained anemia, infections, or bleeding. Early diagnosis facilitates timely interventions, thereby increasing demand for therapeutic options.
Bone Marrow Failure Market Analysis
Currently, two FDA-approved therapies are available for bone marrow failure: REVOLADE/PROMACTA (Novartis) and PIASKY (Chugai Pharmaceutical/Roche).
REVOLADE, marketed globally under this name and as PROMACTA in the US, is an oral thrombopoietin receptor agonist indicated for thrombocytopenia and severe aplastic anemia (SAA), a form of bone marrow failure. It works by stimulating bone marrow activity to increase the production of blood cells, particularly platelets. Eltrombopag is approved for patients with SAA who do not respond to immunosuppressive therapy and can also be used in combination with antithymocyte globulin (ATG) and cyclosporine as part of select first-line regimens. In November 2018, the FDA expanded the indication for PROMACTA to include first-line treatment in combination with standard immunosuppressive therapy (IST) for adults and children aged 2 years and older with SAA. REVOLADE has also received Breakthrough Therapy Designation (BTD) for the management of radiation-induced thrombocytopenia.
PIASKY (crovalimab) is a humanized monoclonal antibody that inhibits complement protein C5. By blocking its cleavage into C5a and C5b, it prevents formation of the membrane attack complex (MAC), thereby reducing intravascular hemolysis and improving symptoms in paroxysmal nocturnal hemoglobinuria (PNH). In August 2024, Roche announced European Commission approval for PIASKY as a treatment for adults and adolescents (≥12 years, ≥40 kg) with PNH, including both treatment-naïve patients and those previously treated with C5 inhibitors.
<img loading="lazy" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=39f7e780-4bbb-4958-99bd-69e7355d63c6&size=0" data-mce-style="display: block; margin-left: auto; margin-right: auto;" data-state="draft" height="420" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/39f7e780-4bbb-4958-99bd-69e7355d63c6/bone-marrow-failure-market.jpg" style="display:block; margin-left:auto; margin-right:auto;" title="Bone-Marrow-Failure-Market.jpg" width="800" />
Learn more about the bone marrow failure treatment options @ Bone Marrow Failure Treatment Guidelines
Bone Marrow Failure Competitive Landscape
The emerging therapies in clinical trials for bone marrow failure include EXG34217 by Elixirgen Therapeutics and CK0801 by Cellenkos.
EXG-34217 is an experimental autologous gene therapy being developed by Elixirgen Therapeutics for bone marrow failure linked to telomere biology disorders (TBDs), including dyskeratosis congenita. The treatment involves modifying a patient’s own CD34⁺ hematopoietic stem cells to express ZSCAN4, a protein that facilitates telomere extension through a telomerase-independent mechanism. By lengthening critically short telomeres, the therapy seeks to restore effective blood cell production in patients with marrow failure.
In February 2025, Elixirgen Therapeutics announced that the FDA had granted Regenerative Medicine Advanced Therapy (RMAT) designation to EXG-34217 for the treatment of TBDs. Around the same time, the therapy also received Orphan Drug Designation. EXG-34217 is currently under evaluation in an ongoing Phase I/II clinical trial (NCT04211714) enrolling patients aged 12 years and older, across all genders and ethnicities, with TBD-related bone marrow failure.
CK0801, developed by Cellenkos, is a first-in-class, off-the-shelf regulatory T-cell (Treg) therapy derived from cord blood. It is designed to address bone marrow failure syndromes, including aplastic anemia, by targeting the inflamed marrow microenvironment. The therapy functions by suppressing overactive cytotoxic T cells, thereby reducing inflammation and potentially reversing hematopoietic suppression.
In June 2019, Cellenkos initiated a Phase I clinical trial of CK0801 in patients with bone marrow failure syndromes such as aplastic anemia, hypoplastic myelodysplasia, and primary myelofibrosis. By delivering functional Tregs, CK0801 aims to re-establish immune balance in the bone marrow and restore normal hematopoiesis.
The anticipated launch of these emerging bone marrow failure therapies are poised to transform the bone marrow failure market landscape in the coming years. As these cutting-edge bone marrow failure therapies continue to mature and gain regulatory approval, they are expected to reshape the bone marrow failure market landscape, offering new standards of care and unlocking opportunities for medical innovation and economic growth.
To know more about new treatment for bone marrow failure, visit @ Bone Marrow Failure Management 
Recent Developments in the Bone Marrow Failure Market
<ul type="disc">
<li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">In February 2025, Elixirgen Therapeutics announced that the FDA had granted Regenerative Medicine Advanced Therapy (RMAT) designation to EXG-34217, its gene therapy candidate for Telomere Biology Disorders (TBDs).</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">In February 2025, Elixirgen Therapeutics announced that the FDA had granted Orphan Drug Designation to EXG-34217, its gene therapy candidate for the treatment of Telomere Biology Disorders (TBDs).</li>
</ul>
Bone Marrow Failure Overview
Bone marrow failure is a serious condition in which the bone marrow—the soft, spongy tissue inside bones that produces blood cells—fails to generate sufficient numbers of red blood cells, white blood cells, or platelets. This deficiency can cause fatigue, recurrent infections, and excessive bleeding. The disorder may arise from inherited syndromes, such as Fanconi anemia or dyskeratosis congenita, or from acquired conditions like aplastic anemia or myelodysplastic syndromes, as well as exposure to toxins, radiation, autoimmune reactions, or certain infections.
Bone marrow failure is generally categorized as either acquired or inherited. Acquired forms usually develop later in life and are not present at birth. Although the exact causes remain unclear, they are often associated with chemical exposures, medications, or underlying diseases. Inherited forms, on the other hand, result from genetic mutations passed from one or both parents.
Bone Marrow Failure Epidemiology Segmentation
The bone marrow failure epidemiology section provides insights into the historical and current bone marrow failure patient pool and forecasted trends for the leading markets (the US, EU4, UK, and Japan). It helps recognize the causes of current and forecasted patient trends by exploring numerous studies and views of key opinion leaders.
The bone marrow failure market report proffers epidemiological analysis for the study period 2020–2034 in the leading markets (the US, EU4, UK, and Japan) segmented into:
<ul type="disc">
<li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">Total Incidence Cases of Bone Marrow Failure</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Total inherited subtypes-specific Incident Cases of Bone Marrow Failure</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Age-specific Incident Cases of Bone Marrow Failure</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Etiology-specific Incident Cases of Bone Marrow Failure </li>
</ul>
Download the report to understand which factors are driving bone marrow failure epidemiology trends @ Bone Marrow Failure Treatment Algorithm
<table style="border-collapse: collapse; border-collapse:collapse ;">
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Bone Marrow Failure Market Report Metrics</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Details</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Study Period</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">2020–2034</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Bone Marrow Failure Market Report Coverage</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan]</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Key Bone Marrow Failure Companies</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Elixirgen Therapeutics, Cellenkos, Novartis, Chugai Pharmaceutical, Roche, and others</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Key Bone Marrow Failure Therapies</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">EXG34217, CK0801, REVOLADE/PROMACTA, PIASKY, and others</td>
</tr>
</table>
Scope of the Bone Marrow Failure Market Report
<ul type="disc">
<li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">Bone Marrow Failure Therapeutic Assessment: Bone Marrow Failure current marketed and emerging therapies</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Bone Marrow Failure Market Dynamics: Conjoint Analysis of Emerging Bone Marrow Failure Drugs</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Competitive Intelligence Analysis: SWOT analysis and Market entry strategies</li>
<li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Bone Marrow Failure Market Unmet Needs, KOL’s views, Analyst’s views, Bone Marrow Failure Market Access and Reimbursement</li>
</ul>
Discover more about bone marrow failure drugs in development @ Bone Marrow Failure Clinical Trials
Table of Contents
<table style="border-collapse: collapse; border-collapse:collapse ;">
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">1</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Key Insights</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Report Introduction</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Executive Summary</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">4</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Events</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">5</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Epidemiology and Market Forecast Methodology of Bone Marrow Failure</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">6</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Overview at a Glance</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">6.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Market Share (%) Distribution of Bone Marrow Failure by Therapies in 2024</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">6.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Market Share (%) Distribution of Bone Marrow Failure by Therapies in 2034</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Disease Background and Overview</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Introduction</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Signs and Symptoms </td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Causes</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.4</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Diagnosis</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">8</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Treatment</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Epidemiology and Patient Population </td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Findings</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Assumptions and Rationale</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Total Incident Cases of Bone Marrow Failure in the 7MM</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">The United States</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Total Incidence Cases of Bone Marrow Failure in the United States</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Total Inherited Subtypes-specific Incident Cases of Bone Marrow Failure in the United States</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Age-specific Incident Cases of Bone Marrow Failure in the United States</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.4</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Etiology-specific Incident Cases of Bone Marrow Failure in the United States</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.5</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">EU4 and the UK</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.6</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Japan</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">10</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Patient Journey of Bone Marrow Failure</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Marketed Bone Marrow Failure Therapies</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Competitors</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">REVOLADE/PROMACTA (eltrombopag): Novartis</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Product Description</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Regulatory Milestone</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Other Development Activities</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.4</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Safety and Efficacy</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.5</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Development</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.5.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Trials Information</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.6</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Analyst Views</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">PIASKY (crovalimab): Chugai Pharmaceutical/Roche</td>
</tr>
<tr>
<td colspan="2" style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">List to be continued in the report…</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Emerging Bone Marrow Failure Therapies</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Competitors</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">EXG34217: Elixirgen Therapeutics</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Product Description</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Other Development Activities</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Development</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.3.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Trials Information</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.4</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Safety and Efficacy</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.5</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Analyst Views</td>
</tr>
<tr>
<td colspan="2" style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">List to be continued in the report…</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market: Seven Major Market Analysis</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Findings</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Outlook</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.3</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Conjoint Analysis</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.4</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Bone Marrow Failure Market Forecast Assumptions</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.5</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Total Bone Marrow Failure Market Size in the 7MM</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.6</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Size by Therapies in the 7MM</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.7</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">The United States Bone Marrow Failure Market Size</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.7.1</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Total Market Size of Bone Marrow Failure in the United States</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.7.2</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Market Size of Bone Marrow Failure by Therapies in the United States</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.8</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">EU4 and the UK Bone Marrow Failure Market Size</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.9</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Japan Bone Marrow Failure Market Size</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">14</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Unmet Needs of Bone Marrow Failure</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">15</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">SWOT Analysis of Bone Marrow Failure</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">16</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">KOL Views of Bone Marrow Failure</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">17</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Access and Reimbursement</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">18</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bibliography</td>
</tr>
<tr>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">19</td>
<td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Report Methodology</td>
</tr>
</table>
Related Reports
Acute Lymphocytic Leukemia Market
Acute Lymphocytic Leukemia Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key acute lymphocytic leukemia companies, including AbbVie, Roche (Genentech), Janssen Research & Development, Pharmacyclics (an AbbVie Company), Incyte Corporation, Novartis, Jazz Pharmaceuticals, Autolus Therapeutics, Syndax Pharmaceuticals, Cellectis, ADC Therapeutics, Wugen, Servier, Allogene, Amgen, Astellas Pharma, Gilead Sciences, Syndax, Incyte, Orca Biosystems, among others.
Follicular Lymphoma Market
Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key follicular lymphoma Market companies, including Merck Sharp and Dohme, AstraZeneca, CRISPR Therapeutics, BeiGene, Nektar Therapeutics, NovalGen, Carna Biosciences, Allogene Therapeutics, Xynomic Pharmaceuticals, Bristol-Myers Squibb, Incyte Corporation, among others.
Multiple Myeloma Market
Multiple Myeloma Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key multiple myeloma companies, including Sanofi, Karyopharm Therapeutics, AbbVie, Takeda Pharmaceutical, Celgene, Bristol-Myers Squibb, RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Celgene, Aduro Biotech, ExCellThera, Janssen Pharmaceutical, Precision BioSciences, Takeda, Glenmark (Ichnos Sciences SA), Poseida Therapeutics, Molecular Partners AG, Chipscreen Biosciences, AbbVie, Genentech (Roche), Janssen Biotech, Nanjing Legend Biotech, Merck Sharp & Dohme Corp., among others.
Myelodysplastic Syndrome Market 
Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key MDS companies, including Bristol-Myers Squibb, Astex Pharmaceutical, Taiho Oncology, Fibrogen, AbbVie, Gilead Sciences, Novartis, Syros Pharmaceuticals, Takeda, Pfizer, Geron Corporation, Karyopharm Therapeutics, Antengene Corporation, BerGenBio ASA, Jazz Pharmaceuticals, Aprea Therapeutics, Sanofi, Medac, among others.
Myeloproliferative Neoplasms Market
Myeloproliferative Neoplasms Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key myeloproliferative neoplasms companies, including Incyte Corporation, Galena Biopharma Inc., Chengdu Zenitar Biomedical Technology Co., Ltd, Eli Lilly and Company, AbbVie, Vion Pharmaceuticals, among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Pipeline Assessment
Healthcare Licensing Services
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect with us on LinkedIn|Facebook|Twitter
<pre>CONTACT: Contact Us Shruti Thakur info@delveinsight.com +14699457679 www.delveinsight.com</pre>
<img alt="" src='https://ml.globenewswire.com/media/NTM5MjVlNTItYzFiZC00NGE3LWEwNDgtNWQyYjIwODQ4MGMzLTEyMDQ5MzgtMjAyNS0wOS0wMS1lbg==/tiny/DelveInsight-Business-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/bone-marrow-failure-market-growth-accelerates-with-advances-in-cell-and-gene-therapy-delveinsight/2025/377523/">Bone Marrow Failure Market Growth Accelerates with Advances in Cell and Gene Therapy | DelveInsight</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>Purva Mantri Takes PM Modi’s ‘Aavati Kalay’ on USA Tour, to Showcase Cultural Heritage</title>
<link>https://dailyindianews.com/purva-mantri-takes-pm-modis-aavati-kalay-on-usa-tour-to-showcase-cultural-heritage/2025/377524/</link>
<dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
<pubDate>Mon, 01 Sep 2025 16:49:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/purva-mantri-takes-pm-modis-aavati-kalay-on-usa-tour-to-showcase-cultural-heritage</guid>
<description><![CDATA[MUMBAI, India, Sept. 01, 2025 (GLOBE NEWSWIRE) — Popular Bollywood folk-pop artist Purva Mantri is set to take Aavati Kalay, the celebrated Garba song penned by PM Narendra Modi and sung by Purva to her upcoming US Dandiya Purvastic Tour. PM Modi dedicated the garba to Goddess Durga during Navratri 2024 also marking his 25th […]
The post <a rel="nofollow" href="https://dailyindianews.com/purva-mantri-takes-pm-modis-aavati-kalay-on-usa-tour-to-showcase-cultural-heritage/2025/377524/">Purva Mantri Takes PM Modi’s ‘Aavati Kalay’ on USA Tour, to Showcase Cultural Heritage</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[<img loading="lazy" decoding="async" alt="Purva Mantri's USA Tour: A Celebration of Indian Culture with PM Modi's 'Aavati Kalay'" height="600" name="GNW_RichHtml_External_IMG" src="https://ml.globenewswire.com/Resource/Download/e418cc4d-00d3-4c88-a41a-c431e4715b5a/ae3ee3.png" width="490" />
MUMBAI, India, Sept. 01, 2025 (GLOBE NEWSWIRE) — Popular Bollywood folk-pop artist Purva Mantri is set to take Aavati Kalay, the celebrated Garba song penned by PM Narendra Modi and sung by Purva to her upcoming US Dandiya Purvastic Tour. PM Modi dedicated the garba to Goddess Durga during Navratri 2024 also marking his 25th Year being in public domain as CM of Gujarat first and then PM of India. The tour begins August 28 which also coincides with the Ganpati festival.
Purva has been personally acknowledged and chosen by the PM after he came across her work and was impressed by her voice and aura. The garba song will now be a centre piece of her US performances, giving international audiences a glimpse of India’s literary and musical heritage.
Purva has earned lot of appreciation and named as “Voice of Festivities” specially in Gujarat for her ultra- high energy performances and powerful singing. Her attempt to connect today’s youth with Divine and countryside music is genuine and lauded. She has been constantly releasing songs encompassed in an EP called 4th Generation to mark her being the 4th generation from her family to be in Divine Music. Her Puneri Dhol performance is unique and has been globally viral.
The tour kicks off in Chicago on August 28, followed by Atlantic City on August 30, Seattle on August 31, and Los Angeles, the entertainment capital of the world, on September 6.
Alongside the performance of Aavati Kalay, Purva will bring vibrant Garba traditions to the fore, blending Gujarati folk rhythms with contemporary street-inspired sounds. Each stop on the tour will feature dandiya night specials and family-friendly festivities, reimagining India’s countryside music culture for a global stage.
Speaking about the upcoming tour, Purva said, “I feel privileged to carry Prime Minister Modi’s garba song Aavati Kalay to international audiences. It is an honour to share India’s folk-pop and street sounds with people from diverse cultures and celebrate the richness of our traditions.”
Following her US performances, Purva will return to India for a marquee Garba event in Ahmedabad and Surat during Navratri.
The Dandiya Purvastic Tour not only celebrates Aavati Kalay but also highlights Purva’s mission to connect Global Youth with Indian Divinity through her musical performances.
Website – https://www.instagram.com/purvamantrisinger?igsh=dmVya3ltaXVsdWJt
Contact Person Name – Sankalp
Email id – admin@purvamantri.com
Disclaimer: This content is provided by the sponsor. The statements, views, and opinions expressed are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented in this article. The content is intended for informational and cultural purposes only and should not be considered as financial, investment, or business advice. Readers are encouraged to independently verify any details of events, tours, or performances mentioned herein. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or consequences arising from reliance on the information provided in this press release. Globenewswire does not endorse any content on this page.
Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e418cc4d-00d3-4c88-a41a-c431e4715b5a
<img alt="" src='https://ml.globenewswire.com/media/MGFlZThiZWItMjViZi00MjcwLTkzNTUtMDE2MDIwY2QyNmY5LTUwMDE1MTI0OC0yMDI1LTA5LTAxLWVu/tiny/Singer-Purva-Mantri.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/purva-mantri-takes-pm-modis-aavati-kalay-on-usa-tour-to-showcase-cultural-heritage/2025/377524/">Purva Mantri Takes PM Modi’s ‘Aavati Kalay’ on USA Tour, to Showcase Cultural Heritage</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
<item>
<title>Smart Healthcare Market Size Set to Cross USD 1,497.89 Billion by 2034: How AI, Telemedicine, and Wearables Are Redefining Patient Care</title>
<link>https://dailyindianews.com/smart-healthcare-market-size-set-to-cross-usd-1497-89-billion-by-2034-how-ai-telemedicine-and-wearables-are-redefining-patient-care/2025/377525/</link>
<dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
<pubDate>Mon, 01 Sep 2025 15:06:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://dailyindianews.com/smart-healthcare-market-size-set-to-cross-usd-1497-89-billion-by-2034-how-ai-telemedicine-and-wearables-are-redefining-patient-care</guid>
<description><![CDATA[According to Precedence Research, the global smart healthcare market size will grow from USD 360.02 billion in 2025 to nearly USD 1,497.89 billion by 2034, with an expected CAGR of 17.18% from 2025 to 2034. The growing prevalence of chronic disease, the focus on enhancing patient care, and technological advancements drive the market growth. Ottawa, […]
The post <a rel="nofollow" href="https://dailyindianews.com/smart-healthcare-market-size-set-to-cross-usd-1497-89-billion-by-2034-how-ai-telemedicine-and-wearables-are-redefining-patient-care/2025/377525/">Smart Healthcare Market Size Set to Cross USD 1,497.89 Billion by 2034: How AI, Telemedicine, and Wearables Are Redefining Patient Care</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></description>
<content:encoded><![CDATA[According to Precedence Research, the global smart healthcare market size will grow from USD 360.02 billion in 2025 to nearly USD 1,497.89 billion by 2034, with an expected CAGR of 17.18% from 2025 to 2034. The growing prevalence of chronic disease, the focus on enhancing patient care, and technological advancements drive the market growth.
Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) — The global smart healthcare market size accounted for USD 418.59 billion in 2026 and is estimated to cross over USD 1,497.89 billion by 2034, forecasted to advance at a double-digit CAGR of 17.18% between 2025 and 2034. Market growth is fueled by the rising prevalence of chronic diseases, increasing adoption of telemedicine and mHealth solutions, and rapid advancements in AI, IoT, and wearable devices.
<img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=17d39881-5020-4913-b0b0-9dfe533162f7&size=3" height="375.06px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/17d39881-5020-4913-b0b0-9dfe533162f7/image1.png" width="666.77px" />
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1173
Smart Healthcare Market Overview
How is Smart Healthcare Market Growing?
Smart healthcare is a platform for the healthcare system that uses technologies like big data, machine learning, Internet of Things, artificial intelligence, and many more to enhance patient care. Smart healthcare focuses on creating personalised, interconnected, and intelligent healthcare infrastructure. It optimizes resource allocation, enhances patient care, and streamlines various operations.
It uses technologies to connect doctors, healthcare providers, patients, and hospitals. Smart healthcare collects data through sources like electronic health records, wearables, and sensors to understand healthcare system performance, patient health, and diseases. Smart healthcare includes remote patient monitoring, smart medication management, wearable devices, AI-powered diagnostics, and smart home healthcare.
Smart Healthcare Market Highlights:
<ul type="disc">
<li style="margin-bottom:8pt;">In terms of revenue, the smart healthcare market is expected to reach USD 360.02 billion in 2025.</li>
<li style="margin-bottom:8pt;">It is forecasted to hit an estimated USD 1,497.89 billion by 2034, driven by digital health innovations and rising chronic disease burden.</li>
<li style="margin-bottom:8pt;">North America held a market share of 17.18% in 2024.</li>
<li style="margin-bottom:8pt;">Asia Pacific region is estimated to expand the fastest CAGR of 24.68% between 2025 and 2034.</li>
<li style="margin-bottom:8pt;">By product, the telemedicine segment registered a maximum market share of 42.42% in 2024.</li>
</ul>
Case Study: Remote Patient Monitoring in Action – A Transformational Shift in Diabetes Care
<img loading="lazy" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=0d3d110f-35bd-4bb8-9f85-034802bffcfb&size=0" data-mce-style="display: block; margin-left: auto; margin-right: auto;" data-state="draft" height="678" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/0d3d110f-35bd-4bb8-9f85-034802bffcfb/chatgpt-image-sep-1-2025-08-28-56-pm.png" style="display:block; margin-left:auto; margin-right:auto;" title="ChatGPT Image Sep 1, 2025, 08_28_56 PM.png" width="452" />
One of the most impactful examples of smart healthcare adoption comes from the integration of remote patient monitoring (RPM) platforms for diabetes management. In India, where nearly 101 million people live with diabetes, healthcare providers have increasingly turned to RPM solutions to reduce hospital visits and improve daily care.
Patients using connected glucometers, wearable patches, and mobile health apps are able to track their blood sugar levels in real time. These data points are automatically transmitted to cloud-based platforms, where AI algorithms analyze fluctuations and alert both patients and physicians of any critical deviations.
A 2024 pilot program run jointly by a leading hospital group in Bengaluru and a digital health startup demonstrated significant outcomes:
<ul>
<li> 30% reduction in hospital admissions linked to diabetic complications. </li>
<li> Improved medication adherence, as patients received personalized reminders via smartphone apps. </li>
<li> Enhanced doctor-patient communication, with physicians able to review health dashboards remotely and adjust treatment plans accordingly. </li>
</ul>
This case underscores the core growth drivers of the smart healthcare market — an aging population, rising prevalence of chronic conditions, and demand for cost-efficient, real-time care delivery. By leveraging connected devices, big data, and AI-driven insights, healthcare systems are moving closer to personalized, proactive, and preventive healthcare.
 Stay ahead of healthcare innovation. Explore Precedence Research subscriptions for continuous access to healthcare and technology market intelligence. Browse Plans Here. 
What are the Growth Factors for the Smart Healthcare Market? 
<ul type="disc">
<li style="margin-bottom:8pt;">The growing prevalence of chronic diseases like cancer, cardiovascular conditions, and diabetes requires continuous monitoring.</li>
<li style="margin-bottom:8pt;">The increasing adoption of telehealth apps, wearable devices, and smartphone apps.</li>
<li style="margin-bottom:8pt;">The strong government support for the digitalization of the healthcare industry.</li>
<li style="margin-bottom:8pt;">The rising demand for personalized medicine and remote patient monitoring.</li>
<li style="margin-bottom:8pt;">The ongoing advancements in medical devices.</li>
</ul>
Top Smart Healthcare Applications in India:
<table style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;">
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Apps</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Features</td>
</tr>
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Tata 1 mg</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
<ol style="list-style-type:decimal;">
<li>Discounts and Savings on Medical Bills</li>
<li>Online Doctor Consultations from Specialists</li>
<li>2000 Types of Lab Tests</li>
<li>Health Check-Ups</li>
<li>Medicines and Personal Hygiene Products Available</li>
</ol>
</td>
</tr>
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Practo</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
<ol style="list-style-type:decimal;">
<li>Provides Reminders</li>
<li>Various Healthcare Services</li>
<li>Online Appointment Booking</li>
<li>Pharmacy Delivery</li>
<li>Coupons for Medical Tests and Blood Tests</li>
</ol>
</td>
</tr>
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">MFine</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
<ol style="list-style-type:decimal;">
<li>Online Treatment, Diagnosis, and Consultations</li>
<li>Chat, Video, and Audio Consultation</li>
<li>Offers a Various Range of Medical Specialities</li>
</ol>
</td>
</tr>
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Netmeds</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
<ol style="list-style-type:decimal;">
<li>Provides Wellness Products, Medical Devices, OTC Medications, and Personal Care Items</li>
<li>Offers Cashback Deals, Discounts, and Promotional Offers</li>
</ol>
</td>
</tr>
<tr>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">PharmEasy</td>
<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
<ol style="list-style-type:decimal;">
<li>Teleconsultation</li>
<li>Medicine Deliveries</li>
<li>Sample Collections and Home Tests</li>
</ol>
</td>
</tr>
</table>
 Smart Healthcare Market Opportunity
What is an Opportunity for the Smart Healthcare Market?
Growing Demand for Remote Patient Monitoring
The growing prevalence of chronic diseases like hypertension, diabetes, & heart disease, and an aging population, increases the demand for remote patient care (RPM). It offers early detection of any potential issues and prevents further complications. It offers customized treatment plans and optimizes patient care. The growing patient demand for making informed decisions and accurate information to monitor health requires RPM. The increasing demand for virtual monitoring and consultations in remote areas increases the adoption of the RPM.
The increasing focus on reducing healthcare costs by healthcare systems and patients increases demand for RPM. The growing advancements, like implantable devices and wearable devices, lead to higher demand for RPM. The growing focus on expanding healthcare in rural communities fuels the adoption of RPM. The growing demand for remote patient monitoring creates the opportunity for the smart healthcare market. 
Limitations and Challenges in the Smart Healthcare Market
What is the Limitation of the Smart Healthcare Market?
High Initial Investment Limits the Adoption of Smart Healthcare
Despite several benefits of smart healthcare in patient care, the high initial investment restricts the market growth. Factors like infrastructure upgrade, customization, stringent security measures, and high technology cost are responsible for the high initial investment. The development of diagnostic tools, medical devices, and sensors is expensive. The IT infrastructure, like powerful computing resources, high-speed networks, and secure data storage, requires a high initial investment.
The development of software for telemedicine, AI-powered analytics, EHRs, and remote patient monitoring requires a high initial investment. The cost of upgrading existing or building new healthcare facilities is high. The growing customization of smart healthcare increases the cost. The high initial investment hampers the growth of the smart healthcare market.
Smart Healthcare Market Key Regional Analysis:
How Big is the U.S. Smart Healthcare Market?
The U.S. smart healthcare market size accounted for USD 69.58 billion in 2024 and is expected to rise from USD 80.86 billion in 2025 to approximately USD 276.00 billion by 2034, at a CAGR of 14.77% from 2025 to 2034.
<img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=57941984-bded-4e54-a59e-3e60a2fc625d&size=3" height="367.56px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/57941984-bded-4e54-a59e-3e60a2fc625d/image2.png" width="653.43px" />
Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/1173
How did North America Dominate the Smart Healthcare Market in 2024?
North America dominated the smart healthcare market in 2024. The well-established technological infrastructure, like a strong presence of technological companies, high-speed internet, and rising smartphone usage, increases focus on the development of smart healthcare. The presence of advanced healthcare systems like personalised medicine, electronic health records, and telehealth services helps the market growth.
The strong government support for smart healthcare solutions and digital health increases the development of smart healthcare infrastructure. The growing prevalence of chronic disease and rising healthcare spending increases demand for smart healthcare solutions. The rapid adoption of connected healthcare technologies like remote patient monitoring, wearable devices, and mHealth drives the overall growth of the market.
<img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=d3c15227-2cbb-404e-9874-ce00ef1fa178&size=3" height="384.4px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/d3c15227-2cbb-404e-9874-ce00ef1fa178/image3.png" width="683.38px" />
Asia Pacific Smart Healthcare Market Trends:
Asia Pacific is experiencing the fastest growth in the market during the forecast period. The growing prevalence of chronic conditions like cardiovascular disease, diabetes, heart attack, hypertension, and many more increases the adoption of smart healthcare technologies for continuous monitoring. The aging population and rising age-related health issues fuel demand for smart healthcare services, helping the market growth.
The rising healthcare spending increases demand for smart healthcare devices like wearable devices. The ongoing technological advancements, like artificial intelligence, sensor technology, and data analytics, increase development in smart healthcare solutions. The strong government support for digital transformation and the increasing expansion of 5G networks drive the market growth.
Smart Healthcare Market Segmentation Analysis
Product Type Analysis:
The telemedicine segment dominated the smart healthcare market in 2024. The growing focus on providing healthcare services in underserved and remote areas increases demand for telemedicine. The increasing patient demand for virtual consultation for convenience and flexibility helps the market growth. The rise in chronic conditions increases the adoption of telemedicine for remote patient management and monitoring. The increasing age-related health problems fuel demand for telemedicine. The growing advancements in communication technology, like wearable technology, video calls, and secure messaging, help in the market growth. The strong government support for telemedicine increases the adoption of telemedicine. The focus on the integration of telemedicine with IoT and AI to enhance diagnostics, remote patient care, and personalised care drives the market growth.
<img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=d3c546ff-17fe-4a06-b532-8298abeb40cb&size=3" height="374.48px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/d3c546ff-17fe-4a06-b532-8298abeb40cb/image4.png" width="665.75px" />
The mHealth segment is the fastest-growing in the market during the forecast period. The growing smartphone penetration and high-speed internet availability increase the adoption of mHealth. The increasing demand for remote healthcare services like management, monitoring, and consultations for health problems helps the market growth. The growing focus on patient empowerment, like wellness programs, medical records, and medication reminders, increases demand for mHealth.
The growing rate of chronic conditions like heart conditions, diabetes, and many more increases the demand for mHealth technologies. The increasing focus on patient-centric care fuels the adoption of mHealth technologies. The rising adoption of wearable devices like fitness trackers and smartwatches supports the market growth.
Top Companies in the Smart Healthcare Market:
<ul type="disc">
<li style="margin-top:5pt; margin-bottom:5pt;">Allscripts – Provides innovative electronic health records (EHR), practice management, and data analytics solutions to improve clinical workflows and patient care.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Logi-Tag Systems – Specializes in RFID-based solutions for real-time tracking and inventory management in healthcare facilities.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Cerner Corporation – Offers comprehensive health information technologies, including EHRs and population health management tools to enhance care delivery.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">SAMSUNG – Develops wearable medical devices and digital diagnostic solutions, contributing to the growing remote and mobile healthcare segment.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Cisco Systems – Delivers secure networking and telemedicine infrastructure that supports connected healthcare systems and real-time communication.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">GENERAL ELECTRIC COMPANY (GE Healthcare) – Provides smart imaging technologies, AI-powered diagnostics, and digital health platforms for better decision-making.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Siemens Healthcare Private Limited – Offers AI-driven diagnostics, smart imaging systems, and digital platforms for hospital efficiency and precision medicine.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">IBM Corporation – Known for IBM Watson Health, it utilizes AI and cloud computing to improve diagnostics, treatment planning, and operational efficiency.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">BD (Becton, Dickinson and Company) – Focuses on connected medication management, diagnostics, and smart medical devices to enhance patient safety and outcomes.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">AirStrip – Enables real-time clinical decision-making through mobile interoperability platforms that deliver patient data to clinicians anytime, anywhere.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Terumo Corporation – Innovates in smart infusion and interventional systems that enhance safety, monitoring, and precision in treatment delivery.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">eClinicalWorks – Offers cloud-based EHR and practice management software with integrated telehealth and patient engagement tools.</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Resideo Technologies, Inc. – Provides smart home health monitoring solutions that support aging-in-place and chronic disease management.</li>
</ul>
Recent Developments:
<ul type="disc">
<li style="margin-bottom:8pt;">In October 2024, Tencent collaborated with Pfizer to launch a smart healthcare innovation ecosystem. The innovation combines big data, cloud computing, and AI with the WeCom and WeChat ecosystem. The integration enhances connectivity between governments, institutions, users, businesses, and healthcare. WeChat offers services like code recognition, searching, and dissemination. (Source: https://www.prnewswire.com)</li>
</ul>
<ul type="disc">
<li style="margin-bottom:8pt;">In April 2025, Baby & Mom Retail launched a new brand, CORVELL, for smart healthcare equipment. The company’s focus is to make smart healthcare solutions more affordable, accessible, and reliable. The products are approved by the Government of India, and the flagship product of the brand is the smart nebulizer. The products are available on e-commerce platforms. (Source: https://www.indianretailer.com)</li>
</ul>
<ul type="disc">
<li style="margin-bottom:8pt;">In March 2025, Airtel Business and Fortis Healthcare launched the Smart Clinics Solution. The solution helps to reach patients across rural and urban areas. The clinics support telemedicine by offering connected medical devices, live health tracking, real-time consultations, secure record management, and advanced point-of-care diagnostics. The clinics focus on a smoother patient experience and better care. (Source: https://telecomtalk.info)</li>
</ul>
Smart Healthcare Market Segments Covered in the Report
By Product Type
<ul type="disc">
<li style="margin-top:5pt; margin-bottom:5pt;">RFID Kanban Systems</li>
<li style="margin-top:5pt; margin-bottom:5pt;">RFID Smart Cabinets</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Electronic Health Records (EHR)</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Telemedicine</li>
<li style="margin-top:5pt; margin-bottom:5pt;">mHealth</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Smart Pills</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Smart Syringes</li>
</ul>
By Region
<ul type="disc">
<li style="margin-bottom:8pt;">North America
<ul type="circle">
<li style="margin-bottom:8pt;">U.S.</li>
<li style="margin-bottom:8pt;">Canada</li>
</ul>
</li>
<li style="margin-bottom:8pt;">Europe
<ul type="circle">
<li style="margin-bottom:8pt;">Germany</li>
<li style="margin-bottom:8pt;">UK</li>
<li style="margin-bottom:8pt;">France</li>
<li style="margin-bottom:8pt;">Italy</li>
<li style="margin-bottom:8pt;">Spain</li>
<li style="margin-bottom:8pt;">Sweden</li>
<li style="margin-bottom:8pt;">Denmark</li>
<li style="margin-bottom:8pt;">Norway</li>
</ul>
</li>
<li style="margin-bottom:8pt;">Asia Pacific
<ul type="circle">
<li style="margin-bottom:8pt;">China</li>
<li style="margin-bottom:8pt;">Japan</li>
<li style="margin-bottom:8pt;">India</li>
<li style="margin-bottom:8pt;">South Korea</li>
<li style="margin-bottom:8pt;">Thailand</li>
</ul>
</li>
<li style="margin-bottom:8pt;">Latin America
<ul type="circle">
<li style="margin-bottom:8pt;">Brazil</li>
<li style="margin-bottom:8pt;">Mexico</li>
<li style="margin-bottom:8pt;">Argentina</li>
</ul>
</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Middle East & Africa
<ul type="circle">
<li style="margin-top:5pt; margin-bottom:5pt;">South Africa</li>
<li style="margin-top:5pt; margin-bottom:5pt;">UAE</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Saudi Arabia</li>
<li style="margin-top:5pt; margin-bottom:5pt;">Kuwait</li>
</ul>
</li>
</ul>
Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1173
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344
Stay Ahead with Precedence Research Subscriptions
Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.
Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web: https://www.precedenceresearch.com
Our Trusted Data Partners:
Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor | Market Stats Insight
Get Recent News: 
https://www.precedenceresearch.com/news
For the Latest Update Follow Us:
LinkedIn | Medium | Facebook | Twitter
✚ Related Topics You May Find Useful: 
<ul type="disc">
<li style="margin-bottom:8pt;">The global smart healthcare products market size accounted for USD 177.17 billion in 2024 and is predicted to reach around USD 515.12 billion by 2034, growing at a CAGR of 11.26% from 2025 to 2034.</li>
<li style="margin-bottom:8pt;">The global smart medical devices market size was estimated at USD 52.66 billion in 2024 and is predicted to increase from USD 59.26 billion in 2025 to approximately USD 168 billion by 2034, expanding at a CAGR of 12.30% from 2025 to 2034.</li>
<li style="margin-bottom:8pt;">The global flexible electronics in healthcare market size accounted for USD 7.00 billion in 2024 and is predicted to increase from USD 8.40 billion in 2025 to approximately USD 43.57 billion by 2034, expanding at a CAGR of 20.70% from 2025 to 2034.</li>
<li style="margin-bottom:8pt;">The global artificial intelligence (AI) in healthcare market size was estimated at USD 26.69 billion in 2024 and is predicted to increase from USD 36.96 billion in 2025 to approximately USD 613.81 billion by 2034, expanding at a CAGR of 36.83% from 2025 to 2034.</li>
<li style="margin-bottom:8pt; text-align:justify;">The global smart hospitals market size accounted for USD 58.18 billion in 2024 and is expected to be worth around USD 296.87 billion by 2034, at a CAGR of 17.7% from 2024 to 2034. </li>
<li style="margin-bottom:8pt;">The global healthcare software as a service market size is estimated at USD 34.84 billion in 2024 and is anticipated to reach around USD 94.56 billion by 2034, expanding at a CAGR of 10.50% from 2024 to 2034.</li>
<li style="margin-bottom:8pt;">The global internet of things (IOT) in healthcare market size is estimated at USD 53.64 billion in 2024 and is anticipated to reach around USD 368.06 billion by 2034, expanding at a CAGR of 21.24% from 2024 to 2034.</li>
<li style="margin-bottom:8pt;">The global augmented and virtual reality in healthcare market size was estimated at USD 3.40 billion in 2024 and it is expected to hit around USD 18.38 billion by 2034, poised to grow at a CAGR of 18.38% during the forecast period 2025 to 2034.</li>
<li style="margin-bottom:8pt;">The global healthcare metaverse market size was calculated at USD 4.77 billion in 2024 and is predicted to increase from USD 6.79 billion in 2025 to approximately USD 144.37 billion by 2034, expanding at a CAGR of 40.64%.</li>
<li style="margin-bottom:8pt;">The U.S. digital health market size was estimated at USD 79.10 billion in 2024 and is predicted to surpass around USD 248.11 billion by 2034, poised to grow at a CAGR of 11.64% from 2025 to 2034. </li>
<li style="margin-bottom:8pt;">The global healthcare information systems market size accounted at USD 519.23 billion in 2024 and is predicted to reach around USD 1773.33 billion by 2034, growing at a CAGR of 13.07% from 2025 to 2034.</li>
<li style="margin-top:5pt;">The global internet of medical things (IoMT) market size accounted for USD 225.81 billion in 2024 and is expected to exceed around USD 2,294.87 billion by 2034, growing at a CAGR of 26.09% from 2025 to 2034.</li>
</ul>
<img alt="" src='https://ml.globenewswire.com/media/NjI3N2UyNDUtYzJhOS00ZmVmLTg5ZWEtMjczMDMxYTEyZGJmLTEyMTM4NDktMjAyNS0wOS0wMS1lbg==/tiny/Precedence-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.
The post <a rel="nofollow" href="https://dailyindianews.com/smart-healthcare-market-size-set-to-cross-usd-1497-89-billion-by-2034-how-ai-telemedicine-and-wearables-are-redefining-patient-care/2025/377525/">Smart Healthcare Market Size Set to Cross USD 1,497.89 Billion by 2034: How AI, Telemedicine, and Wearables Are Redefining Patient Care</a> appeared first on <a rel="nofollow" href="https://dailyindianews.com">Daily India News</a>.
]]></content:encoded>
</item>
</channel>
</rss>

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

Download the "valid RSS" banner.
Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)
Add this HTML to your page (change the image src attribute if necessary):

<a href="http://www.feedvalidator.org/check.cgi?url=https%3A//dailyindianews.com/feed/"><img src="valid-rss-rogers.png" alt="[Valid RSS]" title="Validate my RSS feed" /></a>

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=https%3A//dailyindianews.com/feed/

Home · About · News · Docs · Terms